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Abstract
Spx is a global regulator discovered in Bacillus subtilis to suppress basal growth and
development processes and activate transcription of genes involved in thiol homeostasis when a
cell encounters oxidative stress. Its activity relies on reversible thiol-disulfide bond formation
and binding RNA polymerase rather than DNA. The discovery that Staphylococcus aureus
global virulence regulator, SarA, is more active upon cysteine reduction suggests that redox
response could mediate virulence in this important human pathogen. We describe the cloning of
spx from S. aureus strain RN6390, overexpression in Escherichia coli, and purification of native
protein. Antibodies against Spx were raised for western analysis. Spx from S. aureus was
highly active in a B. subtilis in vitro transcription system, stimulating expression of trxB, the
gene encoding thioredoxin reductase, without reducing agents. RNA polymerase was partially
purified from S. aureus, and the enzyme was active, catalyzing transcription of rpsD, but not
trxB.
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Introduction
The Gram-positive coccus, Staphylococcus aureus, is an important human pathogen,
causing a wide variety of diseases ranging in severity from superficial boils and abscesses to lifethreatening septicemia. Depending on the tissue colonized, an S. aureus infection can result in
bacterial meningitis, endocarditis, osteomyelitis, endophthalmitis, pneumonia, septic arthritis,
toxic shock syndrome, and food poisoning. However, the organism is also part of the normal
human flora, existing innocuously on the skin or in the nasal passages of approximately one-third
of the population. Infection can result when a break in the skin or mucous membranes grants the
commensal microbe access to the bloodstream or other tissues, defining S. aureus as an
opportunistic pathogen, the potency of which can be attributed to its broad range of virulence
factors, ability to withstand many environmental stresses and persist outside the host, and rapid
evolution into multiple-drug resistant strains.
S. aureus is a prominent source of nosocomial infections. This is due in large part to its
ability to colonize medical apparatuses such as catheters, prosthetic implants and valves, and
orthopedic devices. Growth within prostheses allows the bacteria to enter musculoskeletal tissue,
rendering it the leading cause of osteomyelitis (Frederiksen et al., 1993). More important is the
prevalence of multiple-drug resistant isolates within the hospital setting. Treatment options for S.
aureus infections are rapidly becoming obsolete as the number of antibiotic-resistant strains
skyrockets. Methicillin-resistant S. aureus (MRSA) currently constitutes over half of clinical
isolates (Oliveira et al., 2002). The evolution of MRSA strains resistant to vancomycin (BoyleVavra et al., 2001; Weigel et al., 2003), a drug of “last resort,” constitutes an immediate threat to
human health worldwide. The ease with which the organism gains genetic elements to nullify
traditional antimicrobials suggests that researchers must employ innovative strategies in
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approaching the design of therapeutic agents. To this end, the regulatory pathways by which S.
aureus controls virulence factor production must be fully understood.
S. aureus produces two major classes of temporally-regulated virulence factors: cell
wall-associated proteins and secreted exoproteins. The former class includes adhesins such as
the collagen-, elastin-, and fibronectin-binding proteins (cna, ebpS, fnbA and fnbB), intracellular
adhesin (ica), and clumping factor (clfA and clfB) (reviewed in Bronner et al., 2004).
Staphylocoagulase (coa), although it is actually an extracellular protein, is also preferentially
expressed with the surface-associated factors (Lebeau et al., 1994). Expressed in the early stage
of infection or at the onset of exponential growth phase in culture, these proteins allow the
bacteria to colonize host tissue and navigate the bloodstream. Protein A (spa) binds the Fc
portion of circulating antibodies, thus rendering the burgeoning colonies invisible to the host’s
immune system (King and Wilkinson, 1981). A global phenotypic switch occurs later in
infection or during the late exponential phase in culture, whereby the expression of surface
proteins is suppressed in favor of the latter class of virulence factors. The secreted proteins
include exoenzymes, such as proteases (eta, etb, sspA, sspB, and spl), lipase (geh), and nuclease
(nuc), and toxins, including classes of hemolysins (hla, hlb, hld), leukotoxins (luk), enterotoxins,
exotoxins (set), and toxic-shock syndrome toxin (tst) (reviewed in Bronner et al., 2004). In vitro,
this is likened to cells scavenging for nutrients as the requirements of the colony exceed the
resources of the media; in vivo, this may represent a mechanism by which cells release
themselves from attachment sites and disseminate from the primary infection site once it has
been established (Wesson et al., 1998).
The temporal regulation of the above factors is coordinated by a number of
pleiotropically-acting regulators, most notably of the unlinked sar and agr loci, but also
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including sae (Giraudo et al., 1997), ssrAB (Yarwood, et al., 2001), mgr, and several Sar
homologs (sarT, sarU, sarV and rot) (reviewed in Novick, 2003). The agr locus (accessory gene
regulator) consists of two adjacent, divergent transcripts, RNAII and RNAIII, expression of
which are driven by the P2 and P3 promoters, respectively (Peng et al., 1988). RNAII encodes
four genes (agrABCD), which comprise an autoregulatory quorum-sensing circuit with a
classical two-component sensory transduction system having genomic sequence and organization
similar to the comAP operon of Bacillus subtilis (Dubnau et al., 1994). AgrD, the signaling
peptide, is post-translationally processed into an octapeptide pheromone, cyclized, and exported
from the cell by AgrB (Ji et al., 1995). AgrC, a membrane-bound histidine kinase, senses the
extracellular concentration of the signaling peptide, and, once it has reached the minimum
threshold of concentration due to a cell density corresponding to late exponential phase in culture,
phosphorylates the response regulator, AgrA. AgrA, thus activated, binds the P2 and P3
promoters within the agr intergenic region, and upregulates expression of both transcripts
(Koenig et al., 2004). RNAIII, the effector molecule of the system, is an untranslated regulatory
RNA molecule that incidentally includes the open reading frame (ORF) for δ-hemolysin (hld).
RNAIII, by a largely unknown mechanism, operates at the level of transcription and translation
to decrease the production of cell-surface proteins and initiate the secretion of exoproteins
(Novick et al., 1993; Morfeldt et al., 1995; Korem et al., 2005). Mutants lacking any gene of the
agr locus exhibit highly reduced virulence in animal models of disease (Abdelnour et al., 1993;
Cheung et al., 1994; Gillaspy et al., 1995).
The sar (staphylococcal accessory gene regulator) locus was first described as a locus
distinct from agr, which changed the overall pattern of virulence gene expression when
inactivated (Cheung et al., 1992), and then as a gene required for optimal expression of agr

3

(Cheung and Projan, 1994). It contains three overlapping transcripts (sarA, sarB, and sarC) with
a common termination signal (Bayer et al., 1996), and all encode the 14.5 kDa DNA-binding
protein, SarA (Cheung and Projan, 1994). SarA forms a dimer in solution (Rechtin et al., 1999)
and is shown to upregulate expression of both RNAII and RNAIII by binding cis to the P2 and
P3 promoters (Morfeldt et al., 1996; Chien and Cheung, 1998; Chien et al., 1999). Yet sar also
affects expression of virulence determinants independently of agr (Cheung et al., 1994; Blevins
et al., 1999; Chien et al., 1999; Wolz et al., 2000), and mutant strains of S. aureus with sar or
agr mutated can have quite different phenotypes (Cheung et al., 1992; Blevins et al., 1999;
Blevins et al., 2002). Although the literature is inconsistent with regards to whether SarA
represses or induces certain genes, particularly those encoding exoproteins, it does appear to
repress cna and spa transcription (Cheung et al., 1997; Chan and Foster, 1998; Chien et al.,
1999) and enhance fibronectin-binding capacity (FBC) (Cheung et al., 1994; Wolz et al., 2000).
sar mutants show attenuated virulence compared to the wild-type, and sar agr double mutants
have diminished virulence in comparison to agr mutants (Cheung et al., 1994).
For many years, SarA was believed to be a classical transcription factor; however,
mounting evidence to the contrary indicates that it is not. SarA is thought to affect over 100
genes as either an activator or a repressor, and though much of its influence may be through
other regulators, it has been shown to bind directly to promoter regions of a number of target
genes. A number of laboratories have identified different binding sites for SarA within the agr
intergenic region (Morfeldt et al., 1996; Chien and Cheung, 1998; Chien et al., 1999; Rechtin et
al., 1999; Sterba et al., 2003). An AT heptad repeat identified by SELEX (selective evolution of
ligands by exponential enrichment) as a consensus SarA binding site (Sterba et al., 2003) is
present in over 2500 copies within the S. aureus genome (Roberts et al., 2006). SarA is present
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in the cytoplasm in copy numbers far exceeding any known transcription factor (Fujimoto et al.,
unpublished data). SarA has also been shown to influence mRNA turnover, stabilizing cna and
spa transcripts, evidence which suggests that genetic regulation by SarA may not be entirely at
the level of transcription (Roberts et al., 2006).
Confounding an understanding of virulence gene regulation in S. aureus is the discovery
by several laboratories of strain-dependent differences in sar- and agr-mediated gene expression
(Li et al., 1997; Papakyriacou et al., 2000; Blevins et al., 2002; Peacock et al., 2002; Cassat et
al., 2005). The bulk of genetic data on S. aureus has focused on the common laboratory strain
RN6390, or its parent, NCTC8325-4 (Novick, 1967). However, this strain has long been known
to carry an 11-bp deletion in rsbU, which encodes a positive regulator necessary for activation of
the stress response sigma factor, σB, rendering it essentially a sigB mutant (Kullick et al., 1998).
It would therefore be expected that RN6390 would be deficient in its defenses against
environmental stresses, which may, in turn, attenuate virulence; indeed, this appears to be the
case. It is also lacking in cna, which promotes collagen binding. Although wild-type RN6390 is
virulent in animal models of disease, its pathogenicity is greatly attenuated, even when a
chromosomal copy of cna is introduced, in comparison to clinical isolates of S. aureus (Blevins
et al., 2002; Cassat et al., 2005).
Blevins et al. (2002) compared the effects of mutations of agr and/or sar within three
laboratory strains, including RN6390, to those within four clinical isolates, and found a
surprisingly different pattern of virulence gene regulation among the different strains. Although
sar mutants all exhibited increased protease expression and decreased FBC and mutations of agr
brought forth the opposite effect, the impact of these mutations was hardly uniform among the
different strains. For instance, the decrease in protease expression was barely significant in
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clinical isolates but quite obvious in RN6390; however, wild-type RN6390 was shown to be
proteolytically hyperactive compared to wild-type clinical isolates (Blevins et al., 2002). The
significance of this finding is highlighted by the observation that epidemic strains of S. aureus
generally limit exotoxin release to booster host protein-binding capacity, which may favor the
colonization phase of infection (Papakyriacou et al., 2000). Moreover, it was found that the sar
mutant’s diminished FBC was not due to decreased fnb transcription, but the rise in proteolysis,
particularly by sspA. Mutations of sar also produced disparate phenotypes in regard to
hemolysis: in RN6390, hemolysis was negatively impacted by both sar and agr mutations in
accord with the findings of Cheung and Ying (1994); in all other strains tested, the sar mutants
gained hemolysin activity. Again, the hemolysin production of wild-type clinical isolates was
greatly reduced compared to that observed in wild-type RN6390 (Blevins et al., 2002). Finally,
in stark contrast to the findings of Cheung and Projan (1994), mutating sar seemed to have little
effect on RNAIII expression in all strains except RN6390 (Blevins et al., 2002).
Cassat et al. (2005) performed a genome-wide comparison of RN6390, seven sequenced
strains, and two clinical isolates, and used hierarchical clustering to establish that RN6390 is
actually an outlier strain in regards to genetic relatedness. All of the clinical isolates tested were
closely linked, including EMRSA-16, the MRSA dominant in the United Kingdom (Moore and
Lindsay, 2002). These strains were found to be more infective at lower doses than RN6390 and
its close relatives. The researchers also determined that cna, which RN6390 lacks, is not only a
marker for overall virulence, but for genetic relatedness as well (Cassat et al., 2005). This agrees
with an earlier report stating that S. aureus strains which encode cna account for the majority of
human infections (Booth et al., 2001).
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It is apparent from these studies that the regulatory circuits controlled by agr and sar in
RN6390 are not representative of those in clinical isolates, and further characterization of these
global regulators within the background of the laboratory strain may be pointless. What is not
readily apparent is the source or sources of this discrepancy. One possible explanation is that
SarA is not maximally expressed in RN6390 due to the lack of sigB activity. Deora et al. (1997)
purified σB from S. aureus and used it in in vitro transcription of SarA from all three promoters.
They discovered that transcriptional activation from the P3 promoter of sarC, which is
intermediate in size to the other two transcripts, is σB-dependent (Deora et al., 1997). Another
laboratory verified this result in vivo using transcriptional fusion experiments (Manna et al.,
1998). Blevins et al. (2002) also found reduced levels of sarC transcript in RN6390, but it did
not result in decreased SarA production. Another laboratory determined that SarA activity was
dependent not only on functional σB, but growth phase, as well, with maximal SarA expression
occurring during late exponential growth in a sigB-positive strain. They also found agr
expression was increased in sigB mutant strains. σB appeared to have an inhibitory effect on
FBC in this study (Bischoff et al., 2001). It should also be mentioned that at least one laboratory
concluded that σB plays no role in pathogenesis by S. aureus (Chan et al., 1998). So while it is
tempting to suggest that RN6390 has a phenotype similar to a sar mutant because of the rsbU
deletion, definitive evidence remains elusive. An otherwise isogenic strain of RN6390 encoding
functional sigB does exist (Horsburgh et al., 2002). If experiments performed in RN6390 were
replicated in this strain (SH1000), the role of σB in global gene expression could be better
characterized.
The discovery by Bischoff et al. (2001) that optimal SarA expression was dependent not
only on σB, but on growth stage also, suggests that environmental stimuli and stress response
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may be involved in SarA expression and SarA-mediated expression. Chan and Foster (1998b)
examined expression of hla, tst, and several putative extracellular proteases under aerobic and
microaerobic conditions. Their results were rather inconsistent: a sar mutant had ten-fold
accumulation of Hla compared to the wild-type as measured by NH2-terminal sequencing of the
exoprotein profile; the same mutant had 40 % activity relative to wild-type in a hla:lacZ
transcriptional fusion experiment. They did find that SarA seems to be a general repressor of
proteases, in accordance with the bulk of literature on S. aureus, and hypothesized that the
discrepancy concerning Hla accumulation and activation could be a result of proteolysis of Hla
by various secreted proteases, notably a prominent V8 serine protease. They also argued that
differential protease expression could be a mechanism to control a wide range of responses,
including to stresses and environmental stimuli. One rather intriguing piece of evidence pointing
to a potential role for SarA in stress response was that hla activation, as measured by the lacZ
fusion, was dampened in the sar mutant under microaerobic conditions even compared to normal
growth conditions. They also noted that hla expression was induced earlier under microaerobic
conditions (Chan and Foster, 1998b). It seems possible that exponential-phase cells could
behave like post-exponential phase cells when undergoing environmental stress or as the media
becomes depleted of nutrients and saturated with waste products, and this reaction could involve
alternate sigma factors, SarA, and other regulatory networks.
Morfeldt et al. (1996) noted that the spacing between the -35 and -10 elements of P3
promoting RNAIII transcription was three base pairs too long for optimal recognition by RNAP,
and hypothesized that SarA may function to change DNA topology so RNAP and possibly other
regulators could interact with S. aureus promoters (Morfeldt et al., 1996). Supporting this
hypothesis is the intrinsic curvature of DNA within AT-rich tracts that SarA is known to bind to
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(Sterba et al., 2003). SarA activates expression of a murein hydrolase encoded by lrg, and this
activity was shown to be dependent on a region of intrinsic DNA curvature (Fujimoto et al.,
2000). It must be stated, however, that while an early published report of the crystal structure of
SarA binding DNA supported this theory showing SarA overwinding B-DNA into D-DNA upon
contact (Schumacher et al., 2001), a later report found SarA and DNA made more traditional
activator-promoter interactions (Liu et al., 2006). Yet evidence still accumulates that SarA may
more resemble an accessory protein analogous to Xis from Escherichia coli or Integration host
factor (IHF) from bacteriophage λ, which promote intramolecular excision recombination and
Integrase-mediated recombination, respectively (Mumm et al., 2006), than a transcription factor
in the usual sense. SarA could replace Xis in in vitro intramolecular recombination reactions,
although with only modest stimulation of excisional activity, and could bind the bacteriophage λ
attachment site, attL, forming complexes resembling intasomes (Fujimoto et al., unpublished
data). The DNA substrates employed in these assays, attL and attR, contain a site, X, which is
AT-rich (75%), mirroring the AT-richness of the S. aureus genome, and containing a SarA
binding site previously identified by SELEX (Fujimoto et al., unpublished data; Sterba et al.,
2003). This evidence suggests that SarA has a high affinity for AT-rich DNA, such as is found
in UP elements (Ross et al., 1993), and that activation and repression of target genes by SarA
may be an indirect consequence of its chromosomal accessory protein activity.
In the above study, Fujimoto et al. performed competitive enzyme-linked immunosorbent
assays (ELISAs) with cell-free extracts of S. aureus competing against purified SarA for
antibody, and discovered that there are approximately 50,000 SarA dimers per cell at all stages
of growth (Fujimoto et al., unpublished data). This number far exceeds cellular quantities of
known transcription factors, and is similar to amounts of nucleoid accessory proteins found in E.
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coli (Johnson et al., 2005). Fujimoto et al. also determined that, contrary to previous reports
(Bischoff et al., 2001; Manna and Cheung, 2001), SarA is equally active at all stages of growth
in vitro, which caused the researchers to question why the literature continually shows SarA
exerting its regulatory effects in late- and post-exponential stages of growth in vivo. Recalling
the discovery by Chan and Foster (1998b) that SarA activity changed under microaerobic
conditions, Fujimoto et al. performed electromobility shift assays (EMSAs) of SarA binding to
three promoter regions (for agr, cna, and sspA) under oxidizing and reducing conditions. They
observed a dramatic increase of SarA activity when thiol-specific reductants, dithiothreitol
(DTT) and β-mercaptoethanol, were added to the reactions and a decline in activity when
hydrogen peroxide was used. The redox response of SarA was shown to be mediated by its lone
cysteine residue at position nine: the C9A mutant had maximal activity under all conditions
tested. Similarly, SarA’s DNA-binding affinity was also responsive to changes in pH, with
affinity increasing as the pH decreased and optimal binding measured at a pH of 5.5. Again, this
response appears to be dependent on C9, as the C9A mutant’s activity was maximal at a pH of
7.5 (Fujimoto et al., unpublished data). agr expression was earlier found to be favored by low
pH, which may be a consequence of SarA’s binding cis to the agr promoter regions (Regassa and
Betley, 1992; Regassa et al., 1992).
The enhancement of SarA activity caused by low pH and lack of oxygen may explain
why researchers have generally concluded that SarA exerts its regulatory effects during postexponential growth, as culture media tends to accumulate acidic waste products, and denser
colonies may be less efficiently aerated. More importantly, however, is the logical inference that
this may better represent the environment S. aureus encounters during an actual infection, where
conditions will be far from the monospecific, highly aerated, nutrient-rich cultures typically used
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in a laboratory. Within the host, an invading pathogen will encounter environmental stresses
such as release of reactive oxidative species from macrophages, high temperatures induced by
fever, acidic pH of phagolysosomes, and anaerobic conditions found within an abscess. S.
aureus, being a facultative anaerobe, can grow without oxygen, and anecdotal evidence has
pointed to a heightening of virulence when it does, as was seen with toxic shock syndrome.
SarA may therefore be a chromosomal architecture protein which prepares the cell for
environmental stress it will encounter during stationary phase growth while it coordinates
virulence gene regulation with agr and other regulators.
Prokaryotes must contend with oxidative-reductive (redox) stress as a consequence of
aerobic respiration, residence within a host, and competition from other microbes. In general,
redox stress is caused by exposure to reactive oxygen intermediates (ROIs), such as the
superoxide anion (O2·-), hydrogen peroxide (H2O2), and hydroxyl radical (HO·) (reviewed in
Bauer et al., 1999). O2·- and H2O2 are normal byproducts of oxidative phosphorylation, formed
when molecular oxygen oxidizes electron carriers along the respiratory chain. They are also
released from macrophages as part of the host defense to infection. Bacteria secrete redoxcycling antibiotics to inhibit growth of competitors. O2·- destroys iron-sulfur clusters found in
many enzymes. Iron released can react with H2O2 to form HO·, which damages DNA and
oxidizes free thiol residues within proteins into disulfide bonds (reviewed in Storz and Imlay,
1999). Formation of nonnative disulfide bonds causes protein misfolding, and is a common
mechanism for proteins to gain or lose activity (Åslund and Beckwith, 1999). Cytoplasmic
proteins generally do not contain structural disulfide bonds due to the reducing environment
within the cell, but are found in the periplasm (Stewart et al., 1998). O2·-, which cannot cross the
plasma membrane at neutral pH, can combine with nitric oxide (NO·) to form HOONO.
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HOONO can diffuse across the membrane into the cytoplasm, where it is free to attack ironsulfur clusters and free thiols, inactivating enzymes. Alone, NO· blocks respiration by binding
hemes and metal cofactors of enzymes (Storz and Imlay, 1999).
Prokaryotes have evolved a number of different mechanisms to sense and respond to
environmental or cellular increases in oxygen and ROIs (reviewed in Bauer et al., 1999). The
purpose of redox regulation is to maintain a steady state concentration of ROIs that is within the
limit of tolerance (reviewed in Zheng and Storz, 2000). One method by which this aim is
achieved is through induction of genes involved in transport, such as porins and pumps, which
exclude redox-active enzymes to stabilize oxygen levels (Storz and Imlay, 1999). Two of the
best characterized prokaryotic redox regulators are OxyR and SoxR from E. coli. OxyR
functions as a tetramer, with each monomer possessing two cysteine residues. In the normal
reducing environment of the cell, the cysteines exist as free thiols, but an increase in H2O2
concentration oxidizes them into disulfide bonds. OxyR, thus activated, binds upstream
promoter elements of its regulon to upregulate transcription of genes encoding catalase (katG),
alkyl hydroperoxide reductase (ahpF), glutaredoxin (grx), and glutaredoxin reductase (gorA)
(Storz et al., 1990; Zheng et al., 1998). SoxR is a homodimer, which contains four iron-sulfur
clusters. In its reduced form, it is inactive, but is activated by oxidation of the clusters by O2·- or
nitric oxide. Activated SoxR then upregulates the transcription of soxS, which relays the redox
response by initiating transcription of genes such as superoxide dismutase (sodA), aconitase
(acnA), fumarase (fum), and DNA repair enzymes like recA (Ding and Demple, 1997). The
oxidation events that lead to activation of both of these regulators are reversible, so the cascade
of events ceases upon return of the cell to a reduced state (Zheng and Storz, 2000). Another
redox sensor, ArcB, is an intramembrane histidine kinase, which phosphorylates its cognate
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response regulator, ArcC, depending on the redox state of the plasma membrane (Bauer et al.,
1999).
S. aureus is a facultative anaerobe, meaning that it can grow aerobically or anaerobically,
either by fermentation or by respiration, using an alternative terminal electron acceptor to oxygen,
such as nitrate. Therefore, it must have sensory transduction pathways to gauge the oxygen
content of its environment in order to optimize gene expression. One of these systems,
characterized in B. subtilis, is ResDE (Nakano et al., 1996), which has S. aureus homologs,
SrrAB. In B. subtilis, ResDE is required for anaerobic respiration when nitrate is the terminal
electron acceptor. The response regulator, ResD, is constitutively autophosphorylated, but ResE
has phosphatase activity when oxygen is present. Upon oxygen limitation, ResE loses its activity,
and ResD becomes active, inducing transcription of its regulon, which includes essential genes
for anaerobiosis (Nakano et al., 2000b). Another role of oxidoreductases in the cell is to provide
reducing power for biosynthetic enzymes, such as the ribonucleotide reductases which are
necessary for nucleic acid synthesis. The source of reducing power is generally NADPH
(Reichard, 1993). In S. aureus, three classes of ribonucleotide reductases exist, and are
differentially expressed depending on oxygen availability. Class Ib is oxygen-dependent, Class
II is oxygen-independent, and Class III is only expressed during anaerobic growth. This ability
of staphylococci to sense oxygen levels ensures that this essential activity will not be lost
(Masalha et al., 2001).
The first attempt to characterize the transcriptome of S. aureus cells experiencing
oxidative stress was made by Chang et al. (2006). They subjected the cells to hydrogen peroxide
for 10-20 minutes, and analyzed the pattern of gene expression during the onset of, and recovery
from, stress, and noted an initial period of repression of iron storage and transport genes, during
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which time genes involved in fermentation were being upregulated. They concluded that S.
aureus has the ability to induce an anoxic state, and can thus limit its exposure to oxygen and
resultant cytotoxicity (Chang et al., 2006). Another group also reported that suppression of the
tricarboxylic acid cycle through aconitase inactivation actually enhances stationary phase
survival of S. aureus. Their hypothesis was that this is a naturally occurring event, where an
irreversible loss of the iron-sulfur cluster in aconitase renders the pathogen less susceptible to
ROIs produced by host macrophages (Somerville et al., 2002). In light of this evidence, it seems
highly likely that S. aureus can maximize its infectivity through modulation of redox-dependent
gene expression, and that redox sensors and regulators might cooperate with virulence
determinant factors, like SarA, to accomplish this aim.
The discovery that virulence gene regulation by SarA, and perhaps agr, is dependent on
redox has led our laboratory to investigate a novel global redox regulator, spx. This gene was
well characterized in B. subtilis by the group led by Peter Zuber. It has sequence and structural
homology to the enzyme, arsenate reductase (arsC), first located on S. aureus plasmid pI258
(Martin et al., 2001). Arsenate reductase functions in anaerobic respiration, allowing arsenate to
be used as the terminal electron acceptor, and in staphylococci, its activity is dependent on
hydrogen donation by thioredoxin (trxA) and thioredoxin reductase (trxB) (reviewed in Silver
and Phung, 2005). However, Spx was found to be a transcriptional activator and repressor with a
mode of activity unique among known prokaryotic transcription factors.
spx (originally named yjbD) was discovered in B. subtilis as the site of suppressor
mutations that overcame growth and development deficiencies in clpP and clpX strains (Nakano
et al., 2001). The Clp (casinolytic proteolytic) complex is composed of the ClpP proteolytic
subunit and one of three substrate-binding components: ClpX, ClpC, or ClpE. ClpX is an
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ATPase and unfoldase that denatures substrate proteins and translocates them into the proteolytic
chamber of ClpP, imparting specificity in the energy-driven reactions (reviewed in Hecker et al.,
1996). Alone, ClpX acts as a molecular chaperone. It also aids in the displacement of σA, the
housekeeping σ, in favor of σH, the sporulation factor, and stimulates σH-dependent transcription
of sporulation genes (Liu and Zuber, 2000). ClpP functions as a heptamer, and without an
ATPase unit, can only degrade small peptides (Krüger et al., 2000). ClpXP is a crucial member
of the cellular response team to heat and other stresses, and mutations of it are highly pleiotropic,
restricting growth and preventing competence, sporulation, and biosynthesis. Six clpXP
suppressor mutations (denoted cxs) were isolated, and mapped to two unlinked loci: in rpoA,
encoding the α subunit of RNA polymerase (RNAP), specifically helix 1 of the α-carboxy
terminal domain (α-CTD) (Nakano et al., 2000a), and a novel gene, yjbD (Nakano et al., 2001).
Helix 1 is important for interaction with activator domains of transcription factors (Russo and
Silhavy, 1992), and making contacts with UP elements of promoter DNA (Ross et al., 1993;
Gourse et al., 2000). The mutations, Y263C (rpoA cxs-1) and V260A (rpoA cxs-2) changed two
residues that are highly conserved in low GC-content Gram positive bacteria (Nakano et al.,
2000a). Within yjbD, one nonsense (cxs-10) and three missense (cxs-5,-7,-12) mutations were
isolated (Nakano et al., 2001), also in residues that are conserved in yjbD orthologs found in
Gram positive bacteria (Zuber, 2004). yjbD was renamed spx, suppressor of clpX and clpP
(Nakano et al., 2002a).
In addition to regulating proteolysis, ClpXP plays an important role in initiating
transcription of genes required for competence. The development of competence in B. subtilis is
regulated by the intricate com operon. The concentration of ComX, a quorum-sensing
pheromone, is sensed by ComP, a membrane-bound sensory kinase. ComP phosphorylates its
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cognate response regulator, ComA, which, in turn, activates transcription of srf. srf encodes a
peptide, ComS, which liberates ComK, a transcription factor for late competence genes, from an
inhibitory complex. ComK is sequestered by ClpCP and the adaptor protein, MecA, until ComS
replaces it and presents itself as a target for proteolysis. ComK then activates transcription of
itself and genes involved in DNA uptake, repair, and recombination (reviewed in Dubnau et al.,
1994).
In clpP and clpX strains, which did not develop competence, but not in the wild type, Spx
was discovered to bind to the proteolytic complex, and actually enhance the inhibition of ComK
(Nakano et al., 2002a). Western analysis of wild type and mutant strains revealed that Spx is
barely detectable in wild type and clpC cells, but accumulates in clpX and clpP mutants (Nakano
et al., 2002b). Spx has a C-terminus resembling an SsrA peptide tag (Nakano et al., 2003a),
which is co-translationally appended to a truncated peptide, targeting it for degradation by
ClpXP or a similar protease (Weigert and Schumann, 2001). Based on this evidence, and the
phenotypes of clpX/P strains with concurrent restoration of competence in a clpX/P spx double
mutant (Nakano et al., 2001), it seemed likely that ClpXP was necessary for degradation of Spx
in order for cells to overcome Spx-dependent blocks to competence, and, presumably,
sporulation and growth, as well (Nakano et al., 2002b). However, Spx was not degraded by
ClpXP in in vitro proteolytic reactions, but by ClpCP with an adaptor protein (Nakano et al.,
2002b). This puzzling result turned out to be an artifact, caused by two amino acids appended to
the C-terminus of the purified protein after the His-6-tag was cleaved. This was remedied by
cloning the tag onto the N-terminus, where the extension did not affect substrate recognition by
ClpXP, which then successfully proteolyzed Spx in vitro (Nakano et al., 2003b).
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The activity of Spx was further characterized by examining its effect on expression on
srf-lacZ and hmp-lacZ fusion proteins (Nakano et al., 2003b). hmp encodes flavohemoglobin,
and is induced under oxygen-limiting conditions by the two-component ResDE activator
(Nakano et al., 2000b). A clpX strain showed repression of both genes, but this defect was
eliminated in clp cells bearing the rpoAcxs-1, rpoAcxs-2, spxcxs-16 (R52G) or spx null mutations, and
also in the wild type, where Spx is presumably degraded. These data suggested that Spx might
inhibit gene expression by association with the α-CTD of RNAP, a hypothesis which was tested
using a yeast two-hybrid experiment to search for proteins which interact with wild type, but not
mutant alleles, of Spx. Two positive clones both encoded rpoA, and the result was verified with
a pull-down assay. Spx activity was further elucidated by IVT of srf and hmp, transcription of
which was repressed by the addition of Spx to reactions containing promoters with their cognate
activators and wild-type RNAP, but not with cxs alleles. The rpoA mutants, with or without Spx,
transcribed a control gene, rpsD, indicating it encodes an otherwise functional enzyme. The
mechanism by which Spx could interrupt activator-dependent transcription was analyzed using
EMSAs of srf and hmp, where Spx destabilized complexes formed by RNAP, promoters, and
activator proteins (Nakano et al., 2003b). Spx was also shown in vivo to repress genes involved
in transport and utilization of alternative sulfur sources when cells were grown in the presence of
the preferred source, sulfate (Erwin et al., 2005). These experiments convincingly demonstrated
that Spx affects gene expression by an apparently unique mechanism, blocking activatorstimulated transcription by binding to the α-CTD of RNAP, rather than promoter DNA,
prompting Spx to be dubbed an “anti-α” factor (Nakano et al., 2003b).
In order to examine the effects of Spx in vivo in a clpXP+ background, a mutant allele of
Spx (spxDD) was constructed, which removed the SsrA peptide tag-like amino acids from the
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carboxyl terminus (A130D, N131D), rendering it unrecognizable as a substrate for ClpXP.
SpxDD accumulation in otherwise isogenic cells mirrored that of clp strains, and its repression of
srf and nonproductive interaction with rpoAcxs was unchanged. Total RNA was isolated from B.
subtilis strains bearing SpxDD and either wild type RNAP or rpoAcxs-1, and used for microarray
analysis of genome-wide expression. 176 genes were found to be repressed at least three-fold in
cells carrying the wild type allele of rpoA: as expected, these included the srf operon, and also
many genes involved in growth and metabolic processes, such as purine, pyrimidine, and amino
acid biosynthesis (Nakano et al., 2003a). More surprising was the number of genes (106)
induced at least three-fold by the Spx-RNAP interaction (Nakano et al., 2003a), several of whose
products function to regulate thiol homeostasis in the cell, chief among them trxA (thioredoxin)
and trxB (thioredoxin reductase). Nearly half of the affected genes in the transcriptome of
spxDD–expressing cells (Nakano et al., 2003a) followed a similar pattern of induction and
repression to that of B. subtilis cells treated with a thiol-specific oxidant, diamide (Leichert et al.,
2003). Diamide reacts with free thiols to form a disulfide bond with hydrazine as its end product
(reviewed in Kosower and Kosower, 1995). This strong correlation led the researchers to
examine Spx-dependent regulation of trxA, trxB, and srf in cells undergoing diamide-induced
stress using primer extension analysis. As predicted, Spx inhibited transcription of srf, and
activated trxAB when native RNAP was the catalyst. Cells bearing cxs or spx null mutations
were also hypersensitive to growth on 50 µM diamide, indicating Spx to be an important
component of the cellular response to oxidative stress (Nakano et al., 2003a).
Thus, Spx was characterized as a unique global transcriptional regulator that functions to
halt normal growth and metabolism in order to devote the cell’s transcriptional machinery to
cope with thiol-specific oxidative stress, such as that incurred by treatment with diamide. Under
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normal conditions, Spx is proteolyzed by ClpXP, but accumulates under disulfide stress to block
basal transcription, which explains the growth defects observed in clp mutants (Nakano et al.,
2003b). These effects are transient: at the onset of stress, cell growth is arrested, but resumes
after diamide is consumed and detoxified (Leichert et al., 2003). Although suppression of
transcription by Spx is easily envisioned, the mechanism by which it activates genes involved in
the stress response is more mysterious, as it has no DNA-binding domain (Zuber, 2004). Besides
trxAB, Spx induces tpx (thiol peroxidase), msrA (peptide methionine sulfoxide reductase), and
various thioredoxin-like proteins (Nakano et al., 2003a). It could inhibit expression of a
repressor of a target gene, or recruit RNAP to an activator through protein-protein interactions
(Zuber, 2004). Also unclear is how Spx is stabilized under disulfide stress. ClpXP could be
diverted to focus on proteolysis of proteins damaged by oxidation or it could be inactivated itself.
If so, it is likely the ClpX subunit that is affected, because ClpP and ClpC, but not ClpX, are
induced over ten-fold upon diamide treatment (Leichert et al., 2003). The N-terminal of ClpX
has a zinc-finger domain, in which a zinc atom is chelated by five cysteine residues, the
oxidation of which could result in irreversible loss of the bound zinc, and therefore, ClpX
activity (Banecki et al., 2001).
Nakano et al. (2005) explored the mechanism by which Spx activates transcription of
trxB by mutating the highly conserved cysteine residues at positions 10 and 13. These form a
CXXC motif, which is a common feature of redox sensors (OxyR), and a likely candidate for
oxidative sensing and response (Åslund et al., 1999). Cells bearing Spx with either C to A
mutation were hypersensitive to diamide, and could not induce transcription of trxAB. These
residues were not involved in stability of Spx, as either mutant accumulated at the onset of
diamide treatment, indicating that they are involved in transcriptional activation of and/or

19

binding to the α-CTD of RNAP. IVT of trxB could only be accomplished when wild-type Spx
was present in the reaction and was abolished with inclusion of the thiol-specific reductant, DTT,
leading the researchers to conclude that formation of a disulfide bond activates Spx in regards to
positive transcriptional regulation of trxB. They convincingly established that the cysteine
residues at positions 10 and 13 form an intramolecular disulfide bond by performing electrospray ionization mass spectrometry (ESI-MS) on Spx in the presence of an alkylating reagent,
iodoacetamide. Iodoacetamide alkylates free thiol residues. No alkylation was detected unless
DTT was present (Nakano et al., 2005), even when a strong denaturant was added to remove the
possibility that free thiols could be inaccessibly buried within the protein’s hydrophobic core
(Messens et al., 2004). When DTT was added, acetylation occurred, and the resultant species
had a mass similar to an Spx monomer, indicating that an intramolecular, not intermolecular,
disulfide bond had been created. Thus, it was demonstrated that Spx, like OxyR (Storz et al.,
1990), is activated by a thiol-disulfide switch at the onset of thiol-specific oxidative stress, and
this activation is necessary for positive transcriptional regulation (Nakano et al., 2005). By this
mechanism Spx acts as both the sensor and transducer of oxidative stress, as was shown with
OxyR (Storz et al., 1990). The mechanism by which Spx activates transcription is still not clear,
however, as DNase I footprinting revealed no DNA-binding ability of even oxidized Spx at the
trxB promoter (Nakano et al., 2005).
Newberry et al. (2005) solved the crystal structure of Spx in complex with the α-CTD of
RNAP. Spx is composed of two domains: a central domain which interacts with RNAP, and a
redox domain consisting of the N- and C- termini, including the CXXC motif. Oddly, the site of
interaction between Spx and the α-CTD was found to be on the distal face from the redoxsensing motif, opening up the possibility that Spx could induce a conformational change in
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RNAP allosterically that would allow initiation of transcription. Another surprising discovery
was that the affinity of Spx for α was unchanged regardless of oxidation state (Newberry et al.,
2005), in agreement with other reports that reduced Spx could still bind α in footprinting
experiments, though the complex formed was unproductive (Nakano et al., 2005) and that the
redox domain of Spx is nonessential for repression of target genes (Zhang et al., 2006).
Residues within the region of interaction of α with Spx correspond to residues of the E. coli αCTD that are necessary for transcriptional initiation by activator proteins (Chen et al., 2003),
supporting the Spx-dependent repression model (Nakano et al., 2003b; Zhang et al., 2006). Spx
also interacts with residues of B. subtilis α corresponding to the “261” determinant of E. coli α, a
necessary element for recruitment of σ70, the E. coli housekeeping σ (Savery et al., 2002),
prompting the investigators to hypothesize that Spx could activate transcription by facilitating
recruitment of σ to the RNAP core enzyme to form the holoenzyme (Newberry et al., 2005).
As clpXP mutations have such pleiotropic effects in a nonvirulent organism such as B.
subtilis, Frees et al., (2003) investigated whether mutations of either gene could affect virulence
in the pathogen, S. aureus. The researchers constructed deletions of both genes in the common
laboratory strain, 8325-4, which is the parent strain of RN6390 (Novick, 1967), and examined
the resultant change in the overall pattern of expression of genes involved in both virulence and
stress response. Predictably, the stress response was dampened in the clpP mutant, particularly
to heat shock (Frees et al., 2003), as ClpP has long been known to play a crucial role in the
turnover of denatured and otherwise nonnative proteins (Frees and Ingmer, 1999; Krüger et al.,
2000). The strain harboring a clpX deletion was actually more susceptible to many types of
environmental stress, including oxidative stress by hydrogen peroxide. If Spx accumulation is
controlled by ClpXP in S. aureus as it is in B. subtilis, one would assume that these mutants were
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Spx-overproducers and that they would gain oxidoreductase activity, at least in response to thiolspecific oxidative stress. However, the response to diamide was not examined in this study. The
researchers did note an attenuation of virulence in both mutants, probably by both agr-dependent
(represented by decreased hemolysis) and agr-independent (represented by decreased spa
transcription) pathways. Whether these effects involve Spx is not clear (Frees et al., 2003).
Examining the interconnectedness of virulence gene regulatory circuits involving ClpXP, agr,
and SarA and its homologs, Frees et al., (2005) established an absolute requirement of ClpX for
spa and sspA transcription. They also observed repression of clfB and fnbA by both ClpX and
ClpP, although they could not conclude that virulence gene expression was systematically
controlled by ClpXP. Instead they proposed that ClpXP affects virulence through molecular
chaperone activity of other regulators, such as Rot (Frees et al., 2005). Based on the work of the
Zuber laboratory, Spx would surely be another candidate.
The same laboratory constructed a spx deletion strain of 8325-4, and examined changes
in growth and development, stress response, and biofilm formation compared to the clp mutants
and wild-type. Like B. subtilis, S. aureus lacking spx is hypersensitive to diamide; unlike B.
subtilis, S. aureus lacking spx is deficient in biosynthesis and more sensitive to other stresses like
hydrogen peroxide, sub- and superoptimal temperatures, and increased osmotic pressure.
Although S. aureus Spx accumulates in a clp background, indicating it is likely a substrate for
ClpXP, transcription seems to be autoregulated in S. aureus, and induction of stress response by
Spx is not accompanied by increased spx transcription (Pamp et al., 2006) as Peter Zuber’s group
found in B. subtilis (Nakano et al., 2003a). Spx in S. aureus appears to be an important
housekeeping gene, unlike Spx in B. subtilis; this may be because trxB is essential in S. aureus
even under non-oxidizing conditions (Uziel et al., 2004), and its two promoters are both
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dependent on Spx and σA (Pamp et al. 2006). In B. subtilis, trxB transcription is activated by
either σB or σA and Spx (Nakano et al., 2005). Most interestingly, the spx mutant had greatly
enhanced ability to form a biofilm compared to wild-type, even without biofilm-promoting
additives to the media. The researchers concluded that Spx negatively impacts biofilm
production by modulating the expression of icaR, a repressor of the ica operon, which encodes
gene products necessary for the synthesis of polysaccharide intercellular adhesin (PIA) (Cramton
et al., 1999). It is fairly obvious, even from this rather preliminary study, that regulatory events
by Spx from S. aureus are not identical to those by Spx from B. subtilis. This may be due, at
least in part, to its role within the complex layer of regulatory circuits promoting virulence in S.
aureus.
In this study, we have cloned spx from S. aureus laboratory strain RN6390,
overexpressed it in E. coli, and purified the recombinant protein. We also isolated Spx in the
form of inclusion bodies, and used these for production of polyclonal antibodies in rabbits for
western analysis of purified Spx and expression of Spx in whole-cell lysates of RN6390. We
have partially purified the RNAP holoenzyme from RN6390, and created an S. aureus in vitro
transcription (IVT) system for analysis of Spx-dependent activation of trxB. These experiments
were also performed in a B. subtilis IVT system previously described (Liu and Zuber, 2000;
Nakano et al., 2003b; Nakano et al., 2005). S. aureus Spx was highly active in the B. subtilis
IVT system, stimulating transcription of trxB in the absence of a reducing agent. Although
active RNAP was extracted from S. aureus, the preparation had a high level of contaminating
proteins, which may have hindered Spx activity, as Spx-dependent initiation of trxB transcription
could not be demonstrated in the S. aureus IVT system.
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Materials and Methods
Bacterial strains and growth conditions:
Escherichia coli strain One Shot TOPO 10F’ (Invitrogen) was used for TA-cloning of the spx
gene amplified from S. aureus RN6390 genomic DNA. E. coli strain XL1-Blue (Stratagene) was
used for mutagenesis reactions. E. coli strain BL21 (DE3) pLysS (Novagen) was used for
expression of recombinant Spx. E. coli strain DH5α was used for all other sub-cloning reactions
and storage of all plasmids. All E. coli strains except BL21 (DE3) pLysS were grown in LuriaBertani (LB) media at 37 °C with shaking at 225 rpm. For soluble expression of Spx in BL21
(DE3) pLys, cells were grown in Terrific Broth supplemented with 1 M D-sorbitol and 10 mM
betaine HCl at 25 °C while shaking at 150 rpm. For expression of Spx in inclusion bodies for
antibody production, BL21 (DE3) pLys cells were grown as other E. coli strains. For selection
of transformants with TOPO 10F’ and pET9a vectors, kanamycin (Km) was added to the media
at a concentration of 25 µg mL-1. For selection of pLysS in BL21 (DE3) pLysS,
chloramphenicol (Cm) was added to a concentration of 30 µg mL-1. For selection of
transformants with pLL28 in E. coli, spectinomycin (Sm) was added to the media at a
concentration of 50 µg mL-1. S. aureus strain RN6390 was used for partial purification of RNA
polymerase and extraction of genomic DNA. S. aureus cells were grown in brain-heart infusion
(BHI) (Bacto) or tryptic soy broth (TSB) (Bacto) at 37 °C with shaking at 225 rpm and without
antibiotic selection. All strains were stored at -80 °C in growth media with dimethylsufoxide
(DMSO) added to a final concentration of 7 % and antibiotics where necessary.
Purification of genomic DNA:
2 mL of an overnight culture of S. aureus strain RN6390 was pelleted at 6000 g for 5 minutes
and resuspended in 500 µL cold P1 buffer (50 mM Tris-Cl, pH 8.0, 10 mM EDTA) with 100 µg
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RNase A, 200 µg Proteinase K, and 20 µg lysostaphin. The lysate was incubated at 37 °C until
the solution became clear. Phenol extractions were performed with 500 µL phenol equilibrated
to a pH of 8.0 until the interface between organic and aqueous layers was clear. Phenol was
removed from solution by chloroform extractions performed likewise. For all extractions, the
solution was centrifuged for 5 minutes at 15,000 rpm, and the organic layer was discarded. DNA
was subsequently precipitated with 1/10 volume 3 M sodium acetate, pH 5.2, and ¾ volume neat
isopropanol, and the solution was centrifuged for 20 minutes at 15,000 rpm, 4 °C. The pellet
was washed once with 1 mL ice-cold 70 % ethanol, centrifuged for 5 minutes at 15,000 rpm,
4 °C, and dried in a 37 °C incubator. DNA was dissolved in 100 µL EB buffer (10 mM Tris-Cl,
pH 8.5) overnight at room temperature.
Preparation of plasmid DNA:
Plasmid DNA was purified with the Qiagen miniprep and midiprep kits (Qiagen, Inc.) according
to manufacturer’s instructions.
Construction of Spx expression vector:
The Spx coding region was amplified from S. aureus genomic DNA by PCR using primers
oJKM1 and oJKM2, which incorporated Nde I and Bam H1 restriction sites, respectively. The
PCR product was visualized by agarose gel electrophoresis to verify that a product of the correct
size (approximately 400 bp) had been amplified (results not shown). The PCR product was TAcloned into pCR 2.1-TOPO vector (Invitrogen) according to manufacturer’s instructions to make
pJKM10. The Spx coding region was excised from the vector by sequential restriction
digestions with Nde I and Bam H1 enzymes (New England BioLabs) followed by agarose gel
electrophoresis. The band corresponding to Spx was excised from the gel and purified with the
QIAEX II kit (Qiagen) according to manufacturer’s instructions. Purified insert was ligated into
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pET9a expression vector (Novagen) cut with the same enzymes with 1 µL T4 DNA ligase (400
U µL-1) (New England BioLabs) to make pJKM11. The correct nucleotide sequence of the
recombinant gene was confirmed by DNA sequencing (University of Arkansas for Medical
Sciences, Little Rock, AR).
Overexpression and purification of Spx:
Expression host BL21 (DE3) pLysS was transformed with pJKM11 and grown up in 5 mL LBKm-Cm media overnight at 37 °C. The entire overnight culture was then used to inoculate 500
mL Terrific Broth containing 1 M D-sorbitol and 10 mM betaine and appropriate antibiotics.
Cells were grown in 2 L baffled polycarbonate flasks at 25 °C with shaking until the cell density
reached an OD600 of 0.4. Spx overexpression was induced by adding 1 mM isopropy-β-Dthiogalactopyranoside (IPTG), and the cells were grown an additional 24 hours. Cells were
harvested by centrifugation for 10 minutes at 5000 rpm, 4 °C, and pellets were frozen at -20 ºC.
Cells were thawed in 5 mL ice-cold MDJ-50 buffer (50 mM Tris-Cl pH 6.9, 50 mM NaCl, 1 mM
EDTA, 1 mM DTT, and 1 mM phenylmethylsulfonyl fluoride (PMSF)) per gram of wet cell
paste on ice. Cell lysis was achieved by the release of endogenous lysozyme encoded within the
pLysS plasmid carried by the expression host. Chromosomal DNA was sheared by sonication at
30 % power in 15 second intervals until the lysate lost viscosity. The lysate was cleared by
centrifugation for 20 minutes at 14,000 rpm, 4 °C. The supernatant was brought to 55 % of
saturation with solid ammonium sulfate at a rate of 5 g hr-1 while stirring in 4 °C with an
additional hour of stirring, and centrifuged at 10,000 rpm for 10 minutes, 4 °C. The insoluble
fraction was discarded, and the supernatant was brought to 70 % of saturation the same way.
This precipitate was resuspended in 8.5 mL cold MDJ-50 buffer, centrifuged again to remove
insoluble particulates, and desalted into 12 mL of the same buffer with an Econo-Pac 10 DG
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chromatography column (BioRad) in three-3 mL batches according to manufacturer’s
instructions. The desalted solution (12 mL) was applied to a Macro-Prep High S exchange
support column (BioRad). The column was washed first with MDJ-50 buffer until the OD280 of
the wash fell below 0.02, and then washed with MDJ-100 buffer (same buffer with 100 mM
NaCl) the same way. Spx was eluted from the column with MDJ-200 buffer and the column was
cleared with 15 mL MDJ-1000 buffer. 10 µL of each fraction was mixed with an equal volume
of sample buffer, boiled at 95 °C for 5 minutes, and analyzed by 15 % Tricine sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by staining with Coomassie
Brilliant Blue R-250 (Figure 1). The Spx-containing fraction was desalted on an Econo-Pac 10
DG chromatography column into MDJ-50 buffer, and stored in small aliquots at -20 °C with
glycerol added to a final concentration of 10 %. The purity of Spx was estimated to be over
99 %, with an average concentration of 0.5 – 1 mg mL-1, as determined via the Coomassie assay
(Pierce) against bovine serum albumin (BSA) standards and spectrophotometric measurement at
280 nm using an extinction co-efficient of 10,870. The identity of the protein was verified by
western blot analysis and automated Edman degradation of the NH2-terminal ten amino acids
(University of Louisiana Health and Sciences Core Labs, New Orleans, La).
Polyclonal anti-Spx antibody production and western blots:
Recombinant Spx was expressed as described above except that cells were grown in 500 mL LB
media with antibiotics at 37 ºC, and induced with 1 mM IPTG for 3 hours.

When cells were

cultured this way, Spx was found in the insoluble fraction of the lysate, likely in inclusion bodies.
An inclusion body isolation was performed for antibody production. Cells were harvested by
centrifugation at 5000 rpm for 10 minutes, 4 °C, and frozen at -20 °C. The pellet was
resuspended in lysis buffer (50 mM Tris-Cl pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 mM DTT) at
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room temperature for 20 min, and centrifuged at 5000 rpm for 10 minutes, 4 °C. The
spheroplasts were resuspended in 10 mL of the same lysis buffer with 0.1 % sodium
deoxycholate and incubated on ice. 8 mM MgCl2 and 100 µg DNase I were added at 4 ºC. The
inclusion bodies were removed by centrifugation, and washed twice with 10 mL lysis buffer plus
1 % Triton-X. The resultant pellet was dissolved in 2.5 mL of Tricine sample buffer, and boiled
at 95 ºC for 10 min. The entire sample was loaded onto a 15 % Tricine SDS-polyacrylamide gel,
and resolved by electrophoresis. A vertical strip of the gel was stained with Coomassie Brilliant
Blue R-250 and aligned with the gel to reveal the location of Spx, which was excised from the
gel, and sent to Sigma Aldrich for injection into each of two rabbits. The rabbits were injected
with the homogenate three times at two-week intervals, and given an additional booster five days
prior to the final bleed. The serum from the rabbits was used as the primary antibody in
immunoblotting with no further modifications. Purified Spx was resolved by SDS-PAGE, and
transferred onto a polyvinylidene difluoride membrane (PVDF) overnight at 20 V in 4 °C in
Towbin solution (25 mM Tris, 192 mM glycine, 20 % methanol). After blocking non-specific
binding with a 10 % powdered milk phosphate-buffered saline solution with 0.05 % Tween-20
(PBST), the membrane was incubated with anti-Spx primary antibody diluted 1:5000 in PBST
containing 1 % powdered milk. Secondary antibody was goat anti-rabbit linked with horseradish
peroxidase (Amersham) diluted 1:100,000. Antibodies were detected with substrates from the
ECL kit (Amersham) used according to manufacturer’s instructions, and scanned on the
Amersham Biosciences Storm 840 scanner (Figure 2).
Site-directed mutagenesis of Spx:
pJKM11 was used as the template for PCR with the Quick Change site-directed mutagenesis kit
(Stratagene). oJKM3 and oJKM4 introduced a C10A mutation in pJKM11 to make pJKM12.
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oJKM5 and oJKM6 created a C13A mutation to make pJKM13. oJKM7 and oJKM8 mutated
both residues, resulting in a C10/13A change in pJKM14. All reactions were performed
according to manufacturer’s instructions for one amino acid change reactions (16 PCR cycles),
followed by Dpn I digestion of methylated parental template. Reactions were subsequently
purified with the Qiagen PCR Clean-Up kit (Qiagen, Inc.), and used to transform E. coli XL1Blue supercompetent cells (Stratagene). Nucleotide changes were verified by DNA sequencing.
BL21 (DE3) pLysS expression host was transformed by mutant vectors, and expression of
mutant alleles of Spx was attempted using the same protocol as for wild-type Spx (Figure 3).
Partial purification of RNA polymerase holoenzyme from S. aureus and western blots:
4 mL of an overnight culture of RN6390 grown in BHI were used to inoculate 4 x 1 L BHI broth
pre-warmed to 37 °C, which was grown at 37 °C on 225 rpm until cells reached late log phase
(OD560 = 1.2). Cells were harvested by centrifugation at 3500 rpm for 10 minutes, 4 °C, and
frozen at -80 °C overnight. Cells were thawed on ice in 30 mL cold lysis buffer (50 mM Tris pH
7.8, 100 mM NaCl, 5 mM MgCl2, 20 % glycerol, 5 mM β-mercaptoethanol) for 30 minutes, and
resuspended by vortexing. PMSF was added to a final concentration of 1 mM, and cells were
lysed by passing through a French pressure cell press three times at 10,000 psi. The lysate was
cleared by centrifugation at 14,000 rpm for 20 minutes, 4 °C. The cleared lysate was brought to
30 % of saturation with ammonium sulfate, and the resultant pellet was brought to 60 % of
saturation, as stated previously. This pellet was resuspended in 9 mL lysis buffer and dialyzed
overnight in 1 L lysis buffer in 4 °C using a Slide-A-Lyzer dialysis cassette with 7,000 MWCO
(Pierce.) The dialyzed sample was centrifuged at 14,000 rpm for 10 minutes, 4 °C to clear it of
insoluble particulates, and loaded onto a heparin-Sepharose column at the rate of 1 mL min-1.
The column was washed with at least 50 mL of lysis buffer, and proteins were eluted with a 90
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mL linear gradient of lysis buffer containing 100 mM – 1 M NaCl. Column fractions were
analyzed for the presence of β and β’ subunits of RNA polymerase by 12 % SDS-PAGE and
peak fractions were combined. The molarity of NaCl in pooled fractions was calculated, and the
solution was diluted to 100 mM NaCl with lysis buffer containing no salt. The diluted solution
was applied to an Econo-Pac High Q Strong Anion exchange column (BioRad) at a rate of 2 mL
min-1. Proteins were eluted with a linear gradient performed and analyzed as before. Peak
fractions were combined and concentrated in a Centricon Y-10 (Ambion) at 5000 rpm, 4 °C until
volume ≤ 50 µL. Buffer exchange was performed in the concentrator with 1 mL storage buffer
(10 mM Tris pH 8.0, 10 mM MgCl2, 100 mM KCl, 0.1 mM EDTA, 20 % glycerol) and
concentrated to about 50 µL. Neat glycerol was added to a final concentration of 50 %, and the
enzyme was stored at -20 °C. Protein concentration was determined via the Coomassie assay
(BioRad) according to manufacturer’s instructions. Western analysis was performed on
concentrated heparin fractions and dialyzed ammonium sulfate pellet with polyclonal antibody
raised against purified α subunit from B. subtilis (results not shown) and on concentrated High-Q
fractions with anti-Spx from S. aureus generated as described previously (Figure 5). Anti-α was
diluted 1:1000, and secondary antibody, goat anti-rabbit alkaline phosphatase (BioRad), was
used at a dilution of 1:30,000. Anti-Spx was diluted 1:2000. Reactions were developed in
alkaline phosphatase (AP) color development solution, and AP conjugate substrate was added
according to manufacturer’s instructions (BioRad).
In vitro transcription of rpsD and trxB:
Linear DNA templates for in vitro transcription (IVT) were generated by PCR from RN6390
genomic DNA. oJKM9 and oJKM10 amplified a 305 bp fragment including promoters for rpsD,
which encodes a 129 nt major run-off transcript and a 93 nt minor transcript. A 228 bp fragment
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with trxB promoter elements amplified by oJKM10 and oJKM11 encodes a 91 nt run-off
transcript (Uziel et al., 2004). IVT was performed as previously described (Nakano et al., 2005).
Briefly, IVT reactions (20 µL) using B. subtilis RNAP contained 10 mM Tris pH 8.0, 50 mM
NaCl, 5 mM MgCl2, 50 µg mL-1 BSA, 50 nM Spx-free RNAP, 100 nM purified B. subtilis σA,
and 20 nM rpsD or 10 nM trxB in diethylpyrocarbonate (DEPC) water. Reactions catalyzed by
RNAP from S. aureus (approximately 50 nM) were the same but excluded σA. Reactions were
incubated in the presence or absence of 300 nM Spx from S. aureus or B. subtilis and/or 5 mM
DTT for five minutes at room temperature to allow open-complex formation. A ribonucleotide
cocktail (200 µM each GTP, ATP, and CTP, 250 µM UTP, and 5 µCi [α-32P]UTP) was added to
the reaction, which was incubated at 37 °C to initiate transcription. After 20 minutes, the
reactions were precipitated with 2.5 volumes of ice-cold absolute ethanol and 1/10 volume of 5
M ammonium acetate at -20 °C for 30 minutes, and then centrifuged at 14,000 rpm for 20
minutes. Precipitated pellets were resuspended in 5 µL formamide loading dye, boiled at 90 °C
for three minutes, and resolved by denaturing electrophoresis through a 7.6 M urea 8 %
polyacrylamide gel at 550 V. Transcripts were visualized by storage phosphorimaging and
scanned on a phosphorimager (BioRad).
Construction of E. coli-S. aureus shuttle vector to make spx::cat mutant:
spx locus (spx gene with two flanking genes, mecA and trpS) was amplified by PCR from
RN6390 genomic DNA using oJKM13 and oJKM14. The PCR product of approximately 2.9 kb
was precipitated with ethanol, resolved by agarose gel electrophoresis, and excised from the gel.
DNA was purified from the agarose using the QIAEX II kit, and TA-cloned into pCR 2.1-TOPO
to make pJKM20, which was then used to transform TOPO One Shot competent cells. Plasmid
DNA was purified, and the presence of an insert was verified by restriction digest and
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sequencing. pJKM20 was used as the template for PCR with oJKM15 and oJKM16, which
amplified trpS, incorporating Sac I and Not I restriction sites, and with oJKM17 and oJKM18,
which amplified mecA, adding in Bam H1 and Hind III sites. PCR products (the former of 1.6
kb and the latter being 1.3 kb in size) were cloned into pCR 2.1-TOPO as stated above, to make
pJKM21 and pJKM22, respectively. trpS was separated from the vector by sequential digestion
with Not I followed by Sac I, and the product was resolved on 0.7 % low melting-point agarose
gel. E. coli-S. aureus shuttle vector, pLL28, was digested likewise, and electophoresed
alongside trpS. The two bands (trpS and linearized pLL28) were excised from the gel, placed in
separate microcentrifuge tubes, heated to 65 °C for ten minutes, and then removed to 37 °C
heating block. 10 µL of each dissolved gel plug was used in a 50 µL ligation reaction, which
included 5 µL 10 X T4 DNA ligase buffer and 25 µL 10 mM Tris, pH 7.6 at 37 °C. 1 µ T4 DNA
ligase was added to the mixture while vortexing. The reaction was incubated overnight at room
temperature, stopped at 65 °C for ten minutes, and removed to a 37 °C heating block. 10µL of
the ligation product, pJKM23, was used to transform 100 µL E. coli strain DH5α. Plasmid DNA
was purified from an overnight culture of a transformant by miniprep. mecA was sequentially
digested from pCR 2.1-TOPO with Bam H1 followed by Hind III, and ligated into pJKM23 cut
with the same enzymes using the protocol stated above to make pJKM24. Presence of all inserts
was verified by visualization by gel electrophoresis followed by staining with ethidium bromide
and restriction digest. pJKM30 was made like pJKM21 except that oJKM15 and oJKM16 were
used for PCR, which amplified nucleotides 1-163 from the 5’ end of spx along with trpS.
pJKM31 was made likewise, with PCR of pJKM21 amplifying the 3’ end of spx encompassing
nucleotides 250-396 along with mecA. The insert was digested from pJKM31 and ligated into
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pJKM30 to make pJKM32. All restriction enzymes and buffers were purchased from New
England BioLabs.
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Results
Purification of RN6390 genomic DNA:
Genomic DNA was extracted from S. aureus strain RN6390 in order to amplify the gene
encoding Spx to clone into an expression vector and to amplify its flanking genes, trpS and mecA,
for the purpose of creating a vector to delete chromosomal spx. A typical extraction from a 2 mL
overnight culture yielded approximately 20 µg of purified DNA as determined via
spectrophotometric measurement of OD260 using an extinction co-efficient of 50 µg mL-1.
Quality was judged by the ratio of OD260:OD280, which was typically around 1.9, and also by an
OD220 to OD280 spectrophotometric wavelength scan, which showed very low levels of RNA and
protein contamination (results not shown). DNA was also visually inspected by agarose gel
electrophoresis followed by staining with ethidium bromide, and fidelity of DNA was checked
by using it as the template for PCR with oJKM1 and oJKM2, which generated a product of the
correct size (results not shown). Although this yield is rather low, the high quality of DNA
extracted indicates the protocol used was fairly efficient.
Soluble expression and purification of wild-type Spx:
Spx was expressed in recombinant form without any heterologous tags or fusions and purified to
use in IVT of redox genes in order to characterize its transcriptional activity in S. aureus. For
overexpression of recombinant S. aureus Spx, the highly efficient bacteriophage T7 RNAP
encoded within the genome of E. coli expression host was utilized. Induction of protein
expression was accomplished by the addition of 1 mM IPTG after cells reached mid-exponential
growth (OD600 = 0.4), to activate expression of T7 RNAP under control of lacI. Cells were
autolysed by endogenously-expressed lysozyme encoded in the pLysS plasmid carried by the
expression host, which was released by the slow freeze-thaw method. When the expression host
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carrying pJKM11 was cultured in LB broth at 37 °C, overexpressed Spx was found in the
insoluble fraction of the lysate, likely in inclusion bodies (Figure 1, Lanes 1-2). Solubility
problems were surmounted by growing the cells under osmotic shock conditions in 1 M Dsorbitol with 10 mM betaine at 25 °C (Blackwell and Horgan, 1991). When cells were grown
under these conditions, Spx was almost completely soluble in the cleared lysate (Figure 1,
Lanes 3-4). Spx was then purified by a two-step ammonium sulfate precipitation followed by
ion exchange chromatography. The cleared lysate was brought to 55 % of saturation with
ammonium sulfate and pelleted, and this pellet was then brought to 70 % of saturation. This first
separation step rid the preparation of approximately 70 % of contaminating proteins. The
desalted 70 % pellet was bound to the High S-strong cation exchange chromatography column.
At a pH of 6.9, most of the remaining proteins in the E. coli lysate were apparently negativelycharged: they did not bind to or bound very weakly to the column, nearly all the contaminants
being discarded in the flow-through or initial wash (Figure 1, lanes 8-9). The wash with buffer
containing 200 mM NaCl eluted Spx of apparent homogeneity, resulting in a single band which
migrated to 15 kDa as seen by SDS-PAGE, in agreement with the published molecular weight of
Spx (15.4 kDa) (Nakano et al., 2001) (Figure 1, lane 11). Some Spx remained bound to the
High S column, as evidenced by stripping the column of all remaining bound proteins with
buffer containing 1 M NaCl (Figure 1, lane 12), but the protocol was still deemed quite efficient.
Raising the salt concentration of the elution buffer would increase the likelihood of
contamination by proteins that came off in the final wash, as seen by SDS-PAGE. A typical
yield of active Spx was 3 – 5 mg liter of culture -1. The identity of the purified protein was
confirmed by sequencing of the ten NH2-terminal residues via automated Edman degradation
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Figure 1: Soluble expression and purification of recombinant Spx
SDS-PAGE: (10 µL of each sample)
Lane M: Full-Range Rainbow molecular weight marker (Amersham); Lane 1: Insoluble fraction
of lysate from culture grown in LB at 37 °C; Lane 2: Soluble supernatant of same culture; Lane
3: Insoluble fraction of lysate from culture grown in Terrific Broth with 1 M D-sorbitol and 10
mM betaine at 25 °C; Lane 4: Soluble supernatant of same culture; Lane 5: 55 % ammonium
sulfate precipitate; Lane 6: 70 % ammonium sulfate precipitate; Lane 7: Desalted 70 %
ammonium sulfate precipitate; Lane 8: High-S column flow-through; Lane 9: High-S 50 mM
NaCl wash; Lane 10: High-S 100 mM NaCl wash; Lane 11: High-S 200 mM NaCl wash;
Lane 12: High-S 1 M NaCl elution buffer
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(data not shown) and immunoblotting with polyclonal antibodies raised against purified Spx
(Figure 2). Spx is 131 amino acids in length, and has a predicted isoelectric point (pI) of 6.13.
Expression of mutant alleles of Spx:
To better elucidate the mechanism by which Spx activates transcription of redox genes, we
mutated the CXXC region within Spx which comprises the redox domain essential for its
activation activity, mutating each cysteine residue both singly and concertedly. The Quick
Change site-directed mutagenesis kit (Stratagene) was used to mutate the spx coding region in
pJKM11 to construct pJKM12, pJKM13, and pJKM14. Each or both of the two cysteine
residues in Spx was changed to an alanine (C10A in pJKM12, C13A in pJKM13, and C10/13A
in pJKM14). Each of the pET9a constructs expressing mutant alleles of Spx was used to
transform expression host, BL21 (DE3) pLysS. Expression of the mutant Spx alleles was
attempted using the same protocol as for wild-type Spx: slow growth at room temperature in
osmotic shock conditions (1 M D-sorbitol and 10 mM betaine) (Blackwell and Horgan, 1999)
followed by induction of protein expression with 1 mM IPTG. The frozen cell pellets were
autolysed and sonicated as stated for wild-type Spx. The lysate was cleared by centrifugation,
and aliquots of the soluble supernatant and insoluble pellet were analyzed by 15 % Tricine SDSPAGE (Figure 3). All three mutant alleles of Spx were expressed entirely in insoluble form,
likely in inclusion bodies. Repeated attempts to express the mutant proteins did not result in
soluble expression of any of the C to A mutants.
Partial purification of RNA polymerase holoenzyme from S. aureus:
To catalyze Spx-dependent IVT of redox genes, crude preparation of DNA-dependent RNA
polymerase (RNAP) was made from wild-type S. aureus RN6390 cell cultures. Due to its
magnitude in size (437 kDa) (Deora and Misra, 1995) and number of subunits (five), RNA
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Figure 2: Western blot of purified Spx with anti-Spx antibody
Lane 1: 1 µg purified Spx Lane M: Magic-Mark molecular weight marker (Invitrogen)
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Figure 3: Expression of mutant alleles of Spx was insoluble
SDS-PAGE: (15 µL of each sample)
Lane M: Full Range Rainbow molecular weight marker (Amersham); Lane 1: Insoluble fraction
of lysate from cells expressing C10A allele of Spx; Lane 2: Soluble supernatant of same
culture; Lane 3: Insoluble fraction of lysate from cells expressing C13A allele of Spx; Lane 4:
Soluble supernatant of same culture; Lane 5: Insoluble fraction of lysate from cells expressing
C10/13A double mutant allele of Spx; Lane 6: Soluble supernatant of same culture
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polymerase cannot be easily overexpressed in recombinant form using the T7 polymerase system
in E. coli, as was employed for Spx overexpression. There was also no readily available assay
for RNAP activity with which to identify purified fractions of polymerase, although one has been
published (Deora and Misra, 1995). No antibodies to any of the four different subunits (α, β, β’,
or σ) were obtained, except one to B. subtilis α which proved unreactive in western blots (results
not shown). Therefore, visual inspection of SDS polyacrylamide gels for the presence of β and β’
subunits from all of the various fractions collected was the only indicator of the efficacy of this
highly empirical protocol. S. aureus β and β’ have been reported to migrate to 151 and 147 kDa,
respectively, by SDS-PAGE (Deora and Misra, 1995). As they are among the largest proteins
found in the prokaryotic proteasome, they are readily identifiable. S. aureus α (42 kDa) and σ
(55 kDa) (Deora and Misra, 1995) are not as easily apparent on gels, as more contaminating
proteins will be found in this moderately-sized region. α and σ subunits also often show aberrant
mobility in SDS-PAGE (Losick et al., 1970; Lowe et al., 1979). Cells were grown until their
approximate entry into late-exponential growth (OD560 = 1.2) to ensure that protein quantity
would be sufficient, but to minimize the likelihood of isolating RNAP with σB or other alternate
sigma factors associated with stress response (Peter Zuber, personal communication). After
harvesting, cell pellets were frozen overnight at -80 °C, and then lysed by passage through a
French pressure cell press as stated in Materials and Methods. The first purification step
employed was precipitation with ammonium sulfate. The initial cut was to 30 % of saturation
(results not shown), and the supernatant was subsequently brought to 60 % of saturation, and
centrifuged. The insoluble fraction of the 60 % saturated lysate was used for further purification
(Figure 4, Lane 2) after dialysis to remove salt. Previously, the soluble supernatant of the 60 %
fraction had been brought to 80 % of saturation with ammonium sulfate (results not shown).
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Figure 4: Partial purification of RNA polymerase from Staphylococcus aureus
Lane M: Broad-range molecular weight marker (BioRad) Lane 1: Purified 6-His-tagged B.
subtilis RNAP; Lane 2: 60 % ammonium sulfate precipitate of cleared lysate; Lane 3:
Heparin-Sepharose column flow-through; Lane 4: Heparin 100 mM NaCl wash; Lane 5:
Heparin combined peak fractions Lane 6: Heparin concentrated peak fractions Lane 7: High-Q
column flow-through Lane 8: High-Q combined peak fractions; Lane 9: High-Q concentrated
peak fractions
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However, visual inspection of electrophoresed ammonium sulfate fractions did not
unambiguously reveal purified or enriched β and β’ subunits due to the amount of proteins
present. As the 60 % precipitate contained most of the protein in the lysate (Figure 4, Lane 2),
this was the fraction chosen for subsequent purification. The next purification step employed
was binding of the dialyzed 60 % precipitate to a heparin-sepharose column, and elution with a
0.1 – 1 M NaCl gradient. The heparin-sepharose resin consists of a weak cation exchanger with
an affinity ligand, and is routinely used for RNA polymerase preparations (Deora and Misra,
1995; Babcock et al., 1997), though RNA polymerase from heterologous organisms does not
uniformly bind this column (Mani et al., 2006). β and β’ subunits were easily seen on SDS
polyacrylamide gels, as the heparin column chromatography was a much more effective isolation
step than ammonium sulfate precipitation (Figure 4, Lane 5). However, the salt concentration
of the fractions where RNA polymerase eluted was highly variable over the three attempts
undertaken to extract it. In two of the trials, the fractions which eluted at a NaCl concentration
of around 0.85 – 0.95 M were chosen (results not shown); in the other trial, the polymerase
eluted around 0.35 M NaCl (Figure 4, Lane 5). As the latter produced the most homogeneous
preparation, this is the one represented in figures. The only published protocol of S. aureus RNA
polymerase purification reported elution from the heparin-sepharose column at a KCl
concentration of 0.4 – 0.55 M, but this protocol did not involve initial precipitation with
ammonium sulfate (Deora and Misra, 1995). Likely, dialysis did not result in a uniform starting
salt concentration among the three trials, and this led to the wide discrepancy in salt
concentrations of elution buffers. However, this was still the most effective purification step, as
it rid the preparation of approximately 90 % of contaminating proteins. The final purification
step involved binding to the High Q Strong Anion exchanger after dilution of the heparin elutate
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to a NaCl concentration of 0.1 M with salt-free lysis buffer. Bound proteins were eluted with a
linear gradient of 0.1 – 1 M NaCl as before. Fractions containing the β and β’ subunits eluted at
NaCl concentrations between 0.45 – 0.6 M, and were combined (Figure 4, Lane 8). This step
initially seemed to increase the purity of the preparation (Figure 4, compare Lane 5 to Lane 8),
but comparison of concentrated and combined heparin fractions (Figure 4, Lane 6) to the
concentrated and combined Q fractions (Figure 4, Lane 9) shows that the Q column
chromatography only rid the preparation of an estimated 10 - 20 % of contaminating proteins.
Moreover, the Q column, which is highly-positively charged, binds DNA that co-purifies with
RNA polymerase through the heparin column. This benefit, however, is frequently
counterbalanced by the unwanted dissociation of σ factors (Peter Zuber, personal
communication). The combined fractions from the Q column were concentrated and stored at 20 °C in a buffer containing 50 % glycerol, which prevents dissociation of σ from the core
enzyme (Burgess and Jendrisak, 1975). The storage buffer also contained 10 mM MgCl2. This
is within the optimal Mg2+ concentration for activity of B. subtilis RNAP (8 – 12 mM) (Avila et
al., 1971), although S. aureus RNAP has been reported to have maximal activity at Mg2+
concentration between 10 – 30 mM (Deora and Misra, 1995). Overall, the RNA polymerase
preparation was very successful in light of the short time available to optimize the protocol.
Active enzyme was isolated, as evidenced by successful IVT of the rspD gene, but the protocol
was very long, reproducibility was poor, and the yield was quite low. Concentration of RNA
polymerase was determined via the Bradford assay, although non-RNAP proteins may constitute
up to 50 % of the least pure preparation. The preparation of highest fidelity was shown to be
quite dilute, with a concentration of approximately 0.3 µM (Figure 4, Lane 9). A four liter
culture only yielded enough enzyme for 22 IVT reactions from this preparation. A second
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preparation from a six liter culture was much more concentrated (6.2 µM), and produced enough
RNAP to perform over 250 IVT reactions, but with an almost proportionate loss of purity (results
not shown).
Western analysis of partially purified S. aureus RNA polymerase:
To ascertain if RNAP had in fact been isolated from RN6390, western detection of the α subunit
was performed on the polymerase preparation. A western blot was performed on an aliquot of
the combined and concentrated heparin fractions and an aliquot of the dialyzed 60 % ammonium
sulfate pellet from the purest S. aureus RNAP preparation (results not shown). The primary
antibody used was a polyclonal antibody raised against the α subunit of B. subtilis RNAP (a gift
from Peter Zuber). The serum was from the first bleed of the inoculated rabbit, and had never
been tested for activity. Concentrated 6-His-tagged B. subtilis RNAP (a gift from Peter Zuber)
was used as a positive control. Although the primary antibody did react with the purified RNAP
from B. subtilis at the expected molecular weight as judged by comparison with the molecular
weight standards, the resultant band was very weak, and did not appear for nearly one hour after
the addition of AP substrate and conjugate. Three bands appeared in the lane corresponding to
the heparin fractions from the S. aureus RNAP preparation but none migrated to the expected
weight for the α subunit of S. aureus RNAP (42 kDa) (Deora and Misra, 1995). Multiple bands
appeared in the lane corresponding to the dialyzed 60 % ammonium sulfate pellet, and it was
futile to predict if any of them might represent a true reaction with the primary antibody. More
likely, these are the result of a cross-reaction with the goat anti-rabbit secondary antibody with
various antigens from S. aureus, as the ammonium sulfate precipitate contained most of the
proteins found in the S. aureus lysate. Therefore, it proved impossible to predict from this
experiment if RNA polymerase had in fact been extracted. Another western blot was performed
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on the concentrated High-Q fractions from the purest S. aureus RNAP preparation (Figure 5)
using a polyclonal antibody raised against purified S. aureus Spx to determine if Spx co-purifies
with S. aureus RNAP as it seems to in B. subtilis (Peter Zuber, personal communication).
Purified Spx from B. subtilis (a gift of Peter Zuber) (Figure 5, Lane 1) and S. aureus (Figure 5,
Lane 4) were loaded as positive controls, and both reacted with the primary antibody, producing
a single band at the expected molecular weight (15.4 kDa). Spx-free 6-His-tagged B. subtilis
RNAP was loaded as a negative control, and no reaction with anti-Spx antibody was observed
(Figure 5, Lane 2). The concentrated High-Q fractions from the preparation of RNAP from S.
aureus (Figure 5, Lane 3) did not react with the antibody against Spx, indicating that Spx did
not co-purify with RNAP, at least according to the limits of detection in this experiment.
In vitro transcription of S. aureus rpsD:
The activity of partially purified RNAP from S. aureus was tested in a defined in vitro
transcription system. The rpsD gene encodes ribosomal protein S4, and its transcription has
been shown to be unaffected by either Spx activation or repression (Nakano et al., 2003b). It
was therefore used as an indicator of polymerase activity and a negative control for Spxdependent transcriptional regulation. The reactions were performed using a protocol optimized
for IVT with B. subtilis RNAP (Nakano et al., 2005), which differs from published protocols
optimized for IVT with S. aureus RNAP (Deora and Misra, 1995; Deora and Misra, 1996). All
reactions performed with partially purified RNAP from S. aureus were repeated with Spx-free 6His-tagged B. subtilis RNAP holoenzyme which was reconstituted from the core enzyme by the
addition of purified B. subtilis σA (a gift of Peter Zuber). To determine if the S. aureus σA
subunit was present in the RNAP preparation, one reaction was performed where the B. subtilis
σA subunit was added. Based on the nucleotide sequence of the region upstream of the rpsD
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Figure 5: S. aureus Spx did not co-purify with RNA polymerase
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gene, a major transcript of 129 nt and a minor transcript of 93 nt were predicted from the 305 bp
template. The major transcript was predicted from a perfect match to the strong B. subtilis -35
promoter consensus sequence (TTGACA) and a near perfect match (AATAAT) to the -10
promoter consensus sequence (TATAAT). The elements were separated by a 17 bp linker for
optimal RNAP recognition (Moran et al., 1982). The minor transcript was predicted from a
lesser match to the promoter consensus sequences: the -35 promoter (TGTGAA) and -10
promoter (TATATT) were separated by an 18 bp linker. IVT of the S. aureus rpsD gene did
result in two distinct products using both B. subtilis and S. aureus RNAP (Figure 6).
Sequencing reactions were electrophoresed alongside the IVT reactions to verify the sizes of the
transcripts (Fig. 6, Lanes 1-4?). As predicted, a very strong band was seen with an approximate
size of 130 nt based on comparison to the sequencing reactions, and a weaker band migrated to
approximately 90 nt (Figure 6, Lane 1-4) when S. aureus RNAP was used. The addition of 100
nM B. subtilis σA to the S. aureus RNAP preparation produced bands of greater intensity, but of
the same size (results not shown). A reaction catalyzed by the B. subtilis RNAP holoenzyme
produced the major product, but the minor product was not seen, indicating that the less perfect
consensus promoter might not be well recognized by the polymerase from a heterologous
organism (Helmann, 1995). The addition of S. aureus Spx and/or DTT did not affect
transcription of S. aureus rpsD (Figure 6, Lanes 2-4), as was observed for the B. subtilis gene
(Nakano et al., 2005).
In vitro transcription of S. aureus and B. subtilis trxB:
The activation activity of Spx was tested by transcription of trxB, which is highly induced both
in vivo and in vitro by Spx, both in B. subtilis and S. aureus, in a redox-dependent manner
(Nakano et al., 2003a; Nakano et al., 2005; Pamp et al., 2006). IVT was performed from the B.
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Figure 6: S. aureus RNA polymerase was active in in vitro transcription of rpsD
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subtilis trxB template, which produces a transcript of 88 nt (a gift of Peter Zuber). When the 6His-tagged B. subtilis RNAP holoenzyme catalyzed the IVT reactions, no transcription occurred
unless S. aureus Spx was included (Figure 7, Lane 3). Purified Spx from B. subtilis did not
induce transcription from the B. subtilis trxB template (Figure 7, Lane 2), in contrast to previous
findings (Nakano et al., 2005). This failure may be due to the age of the protein preparation, or
repeated freezing and thawing cycles it may have been exposed to. When 5 mM DTT was added
to the reactions, no transcription occurred whether Spx was present or not (Figure 7, Lanes 4-6).
As the S. aureus trxB promoter had been mapped previously (Uziel et al., 2004), a 91 nt
transcript was predicted from the 221 bp template. B. subtilis RNAP was able to recognize the S.
aureus promoters, and produced transcripts of the appropriate size when either B. subtilis Spx
(Figure 7, Lane 8) or S. aureus Spx (Figure 7, Lane 9) were employed in the reactions,
although S. aureus Spx proved to be a much stronger inducer. Again, no transcription resulted
without the addition of Spx (Figure 7, Lane 7) or when DTT was included (Figure 7, Lanes 1012). IVT of S. aureus trxB was attempted using partially purified S. aureus RNAP. A
comparison of the reactions catalyzed by the two different polymerases is presented in Figure 8.
As shown in the previous figure, a transcript was only produced by B. subtilis RNAP in the
presence of S. aureus Spx and absence of DTT (Figure 8, Lane 2). No obvious bands are seen
in the reactions which employed S. aureus RNAP even in the reaction which included S. aureus
Spx and excluded DTT (Fig. 8, Lane 6), in which a transcript was expected. Therefore,
although active polymerase was extracted from S. aureus as shown by the successful
transcription of rpsD, the preparation was not faithful enough to catalyze Spx- and redoxdependent transcription of trxB. This may be due to other transcriptional factors that
contaminated the RNAP preparation, or perhaps the dissociation of the σ subunit.
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Figure 7: S. aureus Spx activates trxB in a Bacillus subtilis transcription system
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Figure 8: Spx from S. aureus, not B. subtilis, activated trxB transcription

51

Discussion
We have expressed recombinant, native Spx and purified it to apparent homogeneity
using a two-step ammonium sulfate precipitation followed by strong cation exchange
chromatography. To our knowledge, this is the first report of purification of Spx from S. aureus,
and the first purification of native Spx from any organism. Characterization of Spx purified
without any tags or heterologous fusions should allow a more thorough characterization of its
activity, as some of the preliminary data on Spx may have been compromised by artifacts of the
6-His-tag employed for purification of various proteins. For example, in vitro proteolysis of Spx
could only be accomplished by ClpCP with an adaptor protein, MecA, due to the loss of the SrrA
peptide tag-like recognition sequence on the C-terminus of 6-His-tagged Spx, while a clpC
mutant showed no concurrent restoration of Spx accumulation (Nakano et al., 2002b). Cloning
the 6-His-tag onto the N-terminal of Spx permitted in vitro proteolysis by ClpXP, in accord with
the in vivo data (Nakano et al., 2003b). The same laboratory also used the inducible, selfcleaving intein tag to purify Spx through a chitin column (Nakano et al., 2001). Spx purified by
this method was reported to bind to a complex consisting of 6-His-tagged MecA, ClpCP, and
ComK in a protein interaction experiment performed using a pull-down assay. Spx was thus
initially thought to repress competence by enhancing the sequestration of ComK by ClpCP and
MecA (Nakano et al., 2002a). However, it was later shown that Spx represses competence by
blocking transcriptional activation of srf by ComK (Nakano et al., 2003b). Moreover, a yeast
two-hybrid experiment which searched for proteins that interact with Spx only yielded positive
clones bearing rpoA (Nakano et al., 2003b). It is possible that Spx could have bound the NiNTA column used in the pull-down assay; indeed, the researchers reported that Spx purified with
the intein tag could bind the Ni-NTA column unless the Spx-expression host was grown in
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copper-free media (Nakano et al., 2002a). Although the intein tag is completely cleaved after
purification (Chong et al., 1997), we still believe that the potential for erroneous data posed by
these heterologous fusions outweighs the convenience of affinity purification, and that
purification of the native protein should always be attempted unless expression of the native gene
would prevent growth of the expression host. Thus, the purification of native Spx reported here
will be a valuable tool in the further study of this important protein.
We have reported purification of DNA-dependent RNA polymerase from S. aureus to
approximately 50 % apparent homogeneity. To our knowledge, this is only the second report of
purification of native RNAP from S. aureus, and no commercial source is available. This
preparation was used for IVT from promoters for the rpsD and trxB genes from S. aureus.
Although RNAP can be easily purified from B. subtilis by overexpressing a 6-His-tagged rpo
subunit (Babcock et al., 1997; Qi and Hulett, 1998), stable transformants in S. aureus are not
readily obtained due to the general inability of staphylococci to undergo double cross-over
recombination (Novick, 1991). Use of native RNAP from S. aureus should lead to a better
understanding and more thorough characterization of its gene regulation, as RNAP from
heterologous organisms might not recognize S. aureus-specific promoters. Also, regulation of a
certain gene in one organism might not involve the same factors as that of another organism,
even if the two are closely related. For instance, transcription of trxB in B. subtilis is activated
by either σB alone or σA in conjunction with Spx (Nakano et al., 2005); in contrast, trxB in S.
aureus is wholly dependent on Spx and σA (Pamp et al., 2006).
The RNAP preparation described in this report contains contaminating proteins when
compared to the 6-His-tagged RNAP from B. subtilis upon polyacrylamide electrophoresis. The
contaminating species were of moderate size, and may be transcription factors or DNA-binding
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accessory proteins. The protocol used to isolate RNAP is expected to purify proteins that bind
DNA, as the heparin column mimics the polarity and negative charges of the phosphate-ribose
backbone of nucleic acids. The protocol employed for RNAP purification is very similar to the
one used to purify recombinant S. aureus SarA, a DNA-binding protein (Rechtin et al., 1999).
Both protocols begin with ammonium sulfate precipitation. The precipitate obtained by 60 %
saturation was used for further purification of RNAP, whereas SarA remains soluble in a solution
saturated to 70 % with ammonium sulfate (Rechtin et al., 1999; this report). However, it was not
directly tested if RNAP was completely insoluble in the solution saturated to 60 % with
ammonium sulfate, and some of the holoenzyme might have been discarded in the supernatant.
Likewise, SarA may be present in the 60 % ammonium sulfate precipitate of the S. aureus lysate.
Both protocols follow the ammonium sulfate treatment with heparin column chromatography.
Since both proteins bind DNA, they bind to the heparin column, and are eluted with a salt
gradient (Rechtin et al., 1999; this report). The final step in both protocols is anion exchange
column chromatography with the High Q column. The High Q column is strongly positivelycharged, and its purpose is essentially to remove contaminating DNA that may have co-purified
with the DNA-binding species isolated by binding to the heparin column, as the negativelycharged phosphate-ribose backbone in nucleic acids will bind the positively-charged resin. Due
to the similarity between the two protocols, it is expected that SarA may, to some extent, copurify with S. aureus RNAP prepared by this method. No band migrated to the molecular weight
of SarA (14.5 kDa) (Cheung and Projan, 1994) as seen by SDS-PAGE analysis (Fig. 4), but the
acrylamide percentage of the gel (12 %) was likely too low to detect a protein of such small size.
Even if a small fraction of cellular SarA co-purifies with S. aureus RNAP, its effect on IVT
could be substantial, due to the extremely high copy number of SarA (Fujimoto et al.,
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unpublished data) and the large proportion of the transcriptome it is thought to regulate (Dunman
et al., 2001).
One contaminating protein that was predicted to co-purify with S. aureus RNAP is Spx;
Spx from B. subtilis is found in preparations of RNAP purified via the 6-His-tagged rpoC
subunit (Peter Zuber, personal communication). The presence of contaminating Spx in the
holoenzyme is believed to be due to Spx’s binding to α, essentially rendering it an additional
subunit of RNAP. Therefore, this group purifies RNAP from a mutant strain of B. subtilis that
lacks Spx (Peter Zuber, personal communication). However, it seems likely that the binding of
Spx to α would be transient, and that the stability of the complex would wane once transcription
had been initiated or blocked. The σ subunit, which dissociates from the core enzyme once the
elongation stage of transcription begins, is frequently lost during purification of RNAP, and
often has to be overexpressed and purified alone, and then added to the core enzyme to
reconstitute the holoenzyme (Hager and Burgess, 1980; Deora and Misra, 1996). Another
plausible explanation for the presence of Spx in the RNAP preparation is that native Spx can, to
some degree, bind the Ni-NTA column used to bind the 6-His-tagged β subunit, as intein-tagged
Spx was shown to do (Nakano et al., 2002a). A western blot was performed on the RNAP
preparation from S. aureus described in this report using antibodies raised against Spx, and no
Spx was detected. However, a second preparation of RNAP was not tested for the presence of
Spx. When IVT was catalyzed by enzyme from this second preparation, weak transcripts were
made from the trxB promoter whether or not Spx was included in the reaction (results not shown),
prompting speculation that Spx had co-purified with RNAP. Due to time constraints, the
experiments could not be repeated to obtain reproducible results. A probable cause of this
discrepancy may be the transient nature of Spx’s binding to α; depending on the stringency of
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this interaction, which itself will rely upon variable conditions such as salt, temperature, and
protein concentration, Spx may dissociate from or co-purify with the holoenzyme. Thus,
different results could be obtained, which may, in part, explain the inconsistency of the data
reported here.
Although the two preparations of RNAP obtained from S. aureus lysates had sufficient
activity to catalyze IVT of the control gene, rpsD, redox- and Spx-dependent transcription of
trxB was not successful. The possible reasons for this failure are numerous, but the impurity of
the holoenzyme probably plays a role in the inefficacy of these experiments. The protocol
employed for purification could be modified to include a final step of size-exclusion
chromatography, as Deora and Misra (1995) utilized in their published report of S. aureus RNAP
purification. The authors used a size-exclusion column with a molecular weight cutoff of 200
kDa, which should remove virtually all contaminating species, particularly since DNA-binding
proteins tend to be rather small. The authors followed heparin column chromatography with
elution through a single-stranded DNA cellulose column (Deora and Misra, 1995). This is
expected to further enrich the solution of DNA-binding proteins, and may also aid in discarding
double-stranded DNA that co-purified with proteins eluted from the heparin column, as the
authors did not make use of the High Q column in this report (Deora and Misra, 1995). A later
report from the same laboratory purified S. aureus RNAP using a modified protocol that omitted
the single-stranded DNA cellulose column, and added ammonium sulfate precipitation and
strong anion exchange column chromatography through the High Q column (Deora and Misra,
1996). These changes render the RNAP purification protocol of Deora and Misra (1996)
essentially identical to the one in this report, except that they included size-exclusion
chromatography as a final step. Since RNAP is one of the largest known prokaryotic proteins,
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this step is expected to be quite efficient in polymerase isolation. It is likely that if our protocol
were modified to include size-exclusion chromatography, the resultant RNAP preparation would
be pure enough to obtain consistent and reproducible data from IVT. We would then expect IVT
from the S. aureus trxB promoter to be successful if S. aureus Spx was included in the reaction
without DTT, as we demonstrated using B. subtilis RNAP.
Another possible explanation of our inability to show Spx-dependent transcription from
trxB is lack of the σA subunit in the RNAP enzyme preparation, as transcription of trxB in S.
aureus relies on the presence of both σA and Spx (Pamp et al., 2006). However, we do not
believe this to be true, as the rpsD gene was successfully transcribed using the same RNAP
preparation. When the S. aureus holoenzyme was supplemented with B. subtilis σA, the
transcripts obtained from the rpsD promoter were of greater intensity, but the banding pattern
was identical to that from the reaction which did not include exogenous σ factor, indicating that
the holoenzyme had been extracted from S. aureus. Adding B. subtilis σA to the IVT reactions
from the trxB promoter likely would have complicated the data by adding further variables, and
did not seem necessary.
Although the S. aureus RNAP preparation was not sufficiently pure to demonstrate Spxdependent transcription of trxB, recombinant S. aureus Spx proved to be highly active in IVT
using B. subtilis RNAP purified via 6-His-tagged rpoC. When 5 mM DTT was included in the
reactions, trxB transcription was inhibited. This finding suggests that, as was shown for B.
subtilis Spx (Nakano et al., 2005), the activation activity of S. aureus Spx is dependent on the
presence of a disulfide bond between cysteine residues 10 and 13. Addition of DTT can quench
transcriptional activation by reducing the disulfide bond to free thiol residues, as occurs with
another redox-sensing prokaryotic transcription factor, OxyR (Storz et al., 1990). Since the vast
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majority of genes that Spx has been shown to positively regulate are involved in thiol
homeostasis (Nakano et al., 2003a), it is logical that once a cell previously suffering from
oxidative stress had returned to its normal, reduced state, transcriptional activation of target
genes by Spx would no longer be necessary or even desirable. The fact that cytoplasmic proteins
rarely contain disulfide bonds due to the reducing environment of the cell (Stewart et al., 1998)
reinforces this notion that gene regulation by Spx should be a transient reaction to cellular stress,
since recovery from oxidative stress will be followed by Spx inactivation.
Spx purified from B. subtilis by a post-translationally cleaved intein tag (Nakano et al.,
2001) had little or no activity in the experiments reported here using this same B. subtilis IVT
system to induce transcription from the trxB promoters of either B. subtilis or S. aureus. We do
not believe, however, that this failure to demonstrate transcriptional activation of trxB with B.
subtilis Spx is scientifically relevant, as B. subtilis Spx purified by this method has been shown
to be active in this IVT system, both in regards to repression and activation of target genes,
including trxB, and other assays as well (Nakano et al., 2003b; Nakano et al., 2005; Zhang et al.,
2006). Moreover, B. subtilis Spx from the same preparation as was used in the experiments
reported here was found to be active at the time these experiments were performed in IVT of
other target genes (Dindo Reyes, personal communication). However, the preparation was
several years old, and the specific aliquots of protein employed in the experiments reported here
may have been subjected to repeated cycles of freezing and thawing, rendering them inactive or
less active. Therefore, it is our belief that the failure to show transcriptional activation of trxB by
B. subtilis Spx in this report is either due to experimental error or reduced activity of the Spx
preparation.
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Since the redox-sensing activity of B. subtilis Spx is dependent on two cysteine residues
which constitute a thiol-disulfide “switch” (Nakano et al., 2005), we attempted to express and
purify recombinant S. aureus Spx mutants that lack one or both of these residues. However,
soluble expression of the three C to A Spx mutants was not achieved. The mutant forms of Spx
were expressed insolubly, probably as inclusion bodies, even when using the modified osmotic
shock protocol (Blackwell and Horgan, 1991) that permitted soluble expression of wild-type Spx.
This raises the possibility that the CXXC motif in Spx is necessary for the translated protein to
fold into the proper conformation, since the C to A alleles of B. subtilis Spx were soluble when
expressed as fusions (Nakano et al., 2005), and we attempted to express the mutant proteins
without tags or fusions. Having these mutant alleles of Spx for IVT from the trxB promoter
could elucidate the mechanism by which the addition of DTT represses transcription, as was
shown in B. subtilis (Nakano et al., 2005). A possible solution to the problem presented by the
inability to express the Spx mutants in soluble form would be to denature the insoluble protein in
urea, and then allow it to refold into the proper conformation. However, this avenue was not
explored as there appeared to be no positive marker for activity of these mutant proteins to
ensure that trxB was not transcribed in vitro due to the loss of the redox sensing motif, and not
merely because the denatured protein was innately inactive. But it was later shown that the
redox sensing motif in B. subtilis Spx is inessential for its repression activity (Zhang et al., 2006).
So it might be possible to denature the insoluble alleles of Spx and test the activity of the
refolded protein in IVT of a gene Spx is known to repress, such as srf in B. subtilis (Nakano et
al., 2003b).
If repression of such a gene could be demonstrated by these refolded mutant alleles of
Spx, then IVT from promoters of genes Spx is thought to activate based on in vivo data could be
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attempted. One could then form a clearer model of the redox dependence of Spx for
transcriptional activation. Many genes in the S. aureus transcriptome that Spx appears to
regulate do not seem to involve redox processes; therefore, it seems likely that formation of an
intramolecular disulfide bond may be only one mechanism by which Spx activates gene
expression. For example, an spx null mutant of S. aureus had enhanced biofilm formation ability,
and this was suggested to be the result of Spx upregulating the biofilm repressor gene, icaR,
apparently independent of oxidation state (Pamp et al., 2006). An advantage of IVT is that the
oxidation state of the reaction can be controlled by the addition of agents such as DTT and
diamide. This control is not easily achieved in vivo, where processes are more dynamic and
conditions harder to measure. The existence of Spx mutants that lack redox sensing ability but
are nevertheless active could facilitate the elucidation of other mechanisms of transcriptional
activation by Spx, if they exist.
Another aim of this project that was not brought to fruition was the creation of an spx null
mutant of S. aureus. A plasmid (pJKM24) was constructed that included the genes which flank
spx on the S. aureus chromosome, trpS and mecA, surrounding cat, which encodes
chloramphenicol acetyltransferase, making it a marker for chloramphenicol resistance on the
staphylococcal integration plasmid, pLL28. It was originally intended that introduction of this
plasmid into S. aureus laboratory strain RN6390 would result in incorporation of cat into the
chromosome at the site of spx following double cross-over recombination events between the
genes flanking spx on plasmid and chromosome. However, another laboratory reported this
event to be extremely rare (Mark Smeltzer, personal communication), which agrees with the
overall consensus that double cross-over recombination is inefficient or nonexistent in
staphylococci (Novick, 1991). Another plasmid (pJKM33) was then constructed in the same
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way except that the 5’ and 3’ ends of spx flanked the cat gene along with trpS and mecA. This
new vector can knock out spx on the chromosome by single cross-over recombination events
followed by excision of the plasmid (Mark Smeltzer, personal communication). Due to time
constraints and the difficulty of transforming staphylococci, the mutant strain of S. aureus was
not made. However, another laboratory recently published a report of a creation of an spx null
mutant of 8325-4 (Pamp et al., 2006), and has offered to share the clone with our group. This
mutant strain could be used in the future to inoculate mice to determine whether Spx contributes,
either positively or negatively, to virulence in S. aureus. We would also like to create a sar spx
double mutant and investigate whether these two important global regulators have a synergistic
or antagonistic effect upon each other.
Some evidence exists that, at least in regards to biofilm production, Spx might attenuate
virulence, and this activity is in opposition to biofilm promotion by SarA. Spx in S. aureus was
found to repress biofilm formation by upregulating transcription of icaR (Pamp et al., 2006), a
repressor of the ica operon, which encodes the enzymes necessary for the synthesis of the
polysaccharide intracellular adhesin (PIA) (Cramton et al., 1999). An earlier report postulated
that SarA promotes biofilm formation by activation of ica, and that σB might antagonize SarAdependent biofilm development. The authors speculated that SarA and σB were indirectly
affecting ica expression, and that another regulator was involved, which would repress ica in a
σB-dependent manner or activate it through SarA (Valle et al., 2003). Biofilm factor expression
is difficult to characterize because so many factors contribute to its regulation: global regulators,
cell density, media additives such as glucose and antibiotics, and environmental cues like
osmolarity, temperature, and redox. In a global analysis of changes in the S. aureus
transcriptome in response to hydrogen peroxide, Chang et al. (2006) noted a halt in ica
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transcription. Based on the later report by Pamp et al. (2006), Spx may be responsible for this
oxidative stress-induced repression of ica, by activation of icaR. In light of this evidence, Spx
appears to be yet another regulator in what is clearly a complex regulatory circuit.
Pamp et al. (2006) also noted important differences in the phenotype of an spx null
mutant of S. aureus compared to the phenotype of an spx mutant of B. subtilis as reported by
Peter Zuber’s group. Whereas inactivation of the spx locus in B. subtilis alleviated growth and
development deficiencies caused by clp mutations (Nakano et al., 2001), spx mutants of S.
aureus were obtained with very low frequency, and the colonies exhibited slow and reduced
growth (Pamp et al., 2006). This is due, at least in part, by the inability of the spx mutant to
express trxB. trxB is an essential gene in S. aureus even in the absence of oxidative stress (Uziel
et al., 2004), and both of its promoters rely on Spx in conjunction with σA (Pamp et al., 2006).
In contrast, trxB in B. subtilis has a σB-dependent promoter in addition to the Spx-dependent one.
It is only essential for survival under oxidizing conditions, as B. subtilis, like S. aureus, lacks the
glutathione/glutaredoxin system found in E. coli (Scharf et al., 1998; Uziel et al., 2004). The
growth defects observed in the spx mutant strain of S. aureus may also arise from the inactivity
of various biosynthetic reductases, as thioredoxin is a hydrogen donor system for these enzymes
(Reichard, 1993). Since S. aureus has no alternative thiol redox system like glutathione and trxB
expression depends on Spx, it is expected that many housekeeping functions would be hindered
or halted in a strain lacking spx. Indeed, it was found that purine, pyrimidine, and amino acid
biosynthesis genes and DNA metabolism genes were both positively and negatively affected by
deleting spx in S. aureus (Pamp et al., 2006), while these housekeeping genes were only
upregulated in spx mutants of B. subtilis (Nakano et al., 2001). Lastly, inactivation of spx in S.
aureus resulted in hypersensitivity to numerous environmental stresses like sub- and
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superoptimal temperatures, salt, and hydrogen peroxide, in addition to diamide (Pamp et al.,
2006), which is the only agent to which spx mutants of B. subtilis are known to exhibit
hypersensitivity (Nakano et al., 2005). Based on this evidence it appears that Spx plays a greater
role in survival and general stress protection in S. aureus than in B. subtilis.
In its role as a global regulator of the general stress response in S. aureus, Spx may carry
out some of the functions that σB performs in other organisms where it has been identified. The
σB regulon of B. subtilis contains many of the components necessary for protection of the cell
from damage caused by a number of environmental stresses (Hecker et al., 1996), and the
discovery of a related alternative sigma factor in S. aureus (Kullick and Giachino, 1997) led to
the assumption that it controlled the general stress response in this close relative of Bacillus. But
although the responses to heat shock, hydrogen peroxide, and acidic pH are controlled by σB in
both organisms, responses to ethanol, salt, and osmotic shock are mediated via σB in B. subtilis
(Boylan et al., 1993) and independently of it in S. aureus (Chan et al., 1998). For instance,
despite the presence of a σB recognition site in the promoter for katA, the sole catalase of S.
aureus, catalase expression and activity was unchanged in the rsbU-positive strain, SH1000,
compared to its otherwise isogenic parent, RN6390, even in cells experiencing oxidative stress
(Horsburgh et al., 2002). A global analysis of gene expression in response to diamide in B.
subtilis found that, although over 20 % of the transcriptome was affected, expression of only a
few σB–dependent genes was altered (Leichert et al., 2003). The transcriptome followed a
strikingly similar pattern of induction and repression to that of clp mutants in which Spx
accumulates (Nakano et al., 2003a). Spx could assume the role of σB in directing gene
expression in response to certain types of stresses, such as disulfide stress, in both organisms. It
is conceivable that this regulation may involve an as-yet undiscovered alternative sigma factor.
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A novel sigma factor, σR, was discovered in Streptomyces coelicolor that induces the thioredoxin
system to combat oxidizing conditions (Paget et al., 1998). Its activity is controlled by a redoxsensing anti-sigma factor, RsrA, by a mechanism analogous to the anti-alpha activity of Spx
(Kang et al., 1999). Under normal conditions, RsrA binds σR, rendering it inactive. When
exposed to diamide or hydrogen peroxide, reversible intramolecular disulfide bond formation
within RsrA causes dissociation of the complex and transcription of the σR regulon. Reestablishment of thiol homeostasis within the cell leads to reduction of RsrA and resumption of
σR repression, completing the negative feedback regulatory loop (Kang et al., 1999).
Repression of target gene activation by Spx has been thoroughly characterized in B.
subtilis, and there is no evidence that it operates differently in S. aureus. The unique mechanism
of Spx-dependent repression is to block activator-stimulated activation of RNAP by physically
hindering protein-protein interaction (Nakano et al., 2003b). The two residues within the α-CTD
of RNAP found to be essential for Spx-dependent repression are V260 and Y263, which lie
within helix 1 of the α-CTD. Helix 1 is important for both activator-dependent transcriptional
activation and the binding of RNAP to UP elements of promoter DNA (Russo and Silhavy, 1992,
Ross et al., 1993). More evidence supporting this “interference model” exists: Spx binds α at
the same residues which are necessary for ComA-dependent activation of srf (Zhang et al., 2006),
and this operon is repressed by Spx both in vivo and in vitro (Nakano et al., 2003b; Zhang et al.,
2006). What remains unclear is whether oxidation of Spx is required for its repression activity.
It is logical to assume that only oxidized Spx should accumulate in the cell, perhaps due to the
diversion of the ClpXP proteolytic machinery. The general view of Spx activity is that Spx
accumulates at the onset of disulfide stress to repress the expression of general housekeeping
functions in order that the cell might devote its resources to combating damage caused by the
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stress, while also activating expression of thioredoxin and other genes that restore thiol balance
(Zuber, 2004). If this is true, then repression and activation by Spx would occur simultaneously;
however, this is hard to test, as the redox motif of Spx has been shown to be unnecessary for
transcriptional repression (Zhang et al., 2006), and the affinity of Spx for α is unchanged by
oxidation state (Nakano et al., 2005). Another gene Spx represses is hmp (Nakano et al., 2003b),
which encodes flavohemoglobin, the expression of which is induced under oxygen-limiting
conditions to allow anaerobic growth (Nakano et al., 2000b). It would seem appropriate that
expression of this gene should be inhibited when oxygen is in excess; however, evidence from S.
aureus suggests that transient anoxic growth in response to oxidative stress can be beneficial to
the cell by limiting additional cytotoxicity caused by ROIs produced during the normal course of
oxidative phosphorylation (Chang et al., 2006).
The activation activity of Spx is more mysterious, and a model to explain it does not yet
exist. It is not apparent how Spx could activate transcription of specific genes when it has no
DNA-binding ability and has not been found to interact with any activator proteins productively
(Zuber, 2004). The crystal structure of oxidized B. subtilis Spx in complex with α-CTD was
solved recently, and the report did suggest a possible mechanism (Newberry et al., 2005).
Structural and genetic data indicate that Spx might activate gene expression by facilitating
recruitment of the σ subunit to the core enzyme (Newberry et al., 2005; Zhang et al., 2006). Spx
was found to interact with residues on α homologous to the “261” determinant of E. coli α
(Newberry et al., 2005), which is important for its interaction with region 4 of σ70, the
housekeeping σ of E. coli (Savery et al., 2002). The site of Spx’s contact with α was shown to
be distal to the CXXC motif, which introduces the possibility that binding of oxidized Spx could
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result in a conformational change within the α-CTD, which would then allow for α-σ interaction,
thus permitting transcriptional activation to proceed (Newberry et al., 2005).
It is also unknown whether disulfide bond formation between cysteines 10 and 13 is the
only mechanism by which transcription is activated by Spx. Newberry et al. (2006) compared
the crystal structure of Spx-α-CTD to the published structure of E. coli ArsC, an Spx homolog,
bound to an arsenate ion (Martin et al., 2001). C10 of Spx aligns with the conserved arsenateligating cysteine in ArsC, and these cysteines are proximal to a conserved arginine residue in
both proteins. The purported role of this residue in both proteins is to lower the pKa of the
reactive cysteine, which would allow for nucleophilic attack of the thiol at physiological pH,
favoring either ligation of the arsenate ion (Martin et al., 2001) or oxidative stress sensing
(Newberry et al., 2005). In both structures it was reported that a sulfate molecule which
originated from the crystallization solution interacted with this arginine residue. The
significance of this finding is highlighted by the discovery that when B. subtilis is grown with
sulfate as its sole sulfur source, Spx regulates expression of genes involved in sulfur assimilation
and metabolism (Erwin et al., 2005). This suggests that activation of Spx could be affected by
other mechanisms in addition to thiol oxidation, which may be especially relevant when
considering environmental sensing by S. aureus Spx, which controls the response to more types
of stress than does its homolog in B. subtilis (Pamp et al., 2006).
Another factor complicating a model of transcriptional control by Spx in S. aureus is the
global regulator, SarA. This study did not attempt to discover a link between the regulatory
pathways of Spx and SarA, but that is a future research directive of our group. SarA does share
some of the defining characteristics of Spx. It affects the expression of hundreds of genes as
both an activator and a repressor, and is responsive to redox. Unlike Spx, SarA is a DNA-
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binding protein. But, although consensus sequences of preferred SarA recognition sites have
been found, SarA also can bind DNA promiscuously (Sterba et al., 2003), and may do so in vivo
in a non-sequence specific manner. SarA binds AT-rich DNA with high affinity (Sterba et al.,
2003). Since UP elements which are bound by α-CTD are comprised of AT-rich sequences,
SarA’s repression activity may be to outcompete RNAP for these activation elements, a mode of
repression with obvious analogies to that of Spx. SarA experiences a great increase in activity
upon reduction of its sole cysteine residue, while Spx is activated by oxidation of its cysteine
residues. Since Spx induces the expression of genes involved in thiol reduction, it is possible
that Spx enhances regulation by SarA. Another scenario posits that only one of the two global
regulators would be active at any specific timepoint, depending on growth phase and external
conditions, such as pH and redox. In this manner, SarA and Spx could coordinate virulence gene
regulation and stress response. This might explain why preliminary data shows antagonistic
gene regulation by SarA and Spx in regards to biofilm production (Valle et al., 2003; Pamp et al.,
2006).
In order to develop an accurate model of global gene regulation by SarA and Spx, it will
be necessary to construct S. aureus strains lacking either and both of these regulators. Although
in vitro experiments can be helpful in elucidating a particular mechanism of activity, the
potential for mistaking artifacts for real data is always present, and hypotheses formulated based
on in vitro results should be verified in vivo. Most importantly, for the same reasons that
pathogenesis should be studied using clinical, rather than laboratory, strains, examination of
virulence gene expression should not be separated from the stress response. Pathogens produce
virulence factors within the confines of a host, which is concomitantly mounting an immune
response and defense. This defense can involve a number of factors, such as changes in
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temperature, pH, redox, and cellular responses like phagocytosis and release of complement and
cytokines, any or all of which can antagonize or aid in the offense presented by the pathogen. In
essence, it can be postulated that both host and pathogen present an offense and a defense, and
each must synchronize its own gene expression to maximize the potential of both in order to
survive. If studies of virulence expression by prokaryotes were moved away from the ideal
conditions of a laboratory into an environment which resembles one that these organisms
actually encounter, perhaps more meaningful discoveries would follow.
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Appendix I
Primers used:
oJKM1: amplify spx from RN6390 incorporating Nde I site
5’ AGAGTGAGACATATGGTAACATTATTTACT 3’
oJKM2: reverse primer for oJKM1 incorporating Bam H1 site
5’ TAGTAAAGTAGGATCCATAGTTAAATGGTT 3’
oJKM3: introduce C10A mutation into Spx
5’ TTTACTTCACCAAGTGCTACATCTTGCCGTAAAG 3’
oJKM4: reverse primer for oJKM3
5’ CTTTACGGCAAGATGTAGCACTTGGTGAAGTAAA 3’
oJKM5: introduce C13A mutation into Spx
5’ CCAAGTTGCACATCTGCTCGTAAAGCGAAAGC 3’
oJKM6: reverse primer for oJKM5
5’ GCTTTCGCTTTACGAGCAGATGTGCAACTTGG 3’
oJKM7: introduce C10/13A mutation into Spx
5’ CCAAGTGCTACATCTGCTCGTAAAGCGAAAGC 3’
oJKM8: reverse primer for oJKM7
5’ CGTTTCGCTTTACGAGCAGATGTAGCACTTGG 3’
oJKM9: amplify rpsD fragment with promoter from RN6390 incorporating EcoR1 site
5’ GCGAATTCCGGCGTCTTAGATATCGATGCC 3’
oJKM10: reverse primer for oJKM9 incorporating Bam H1 site
5’ CGGGATCCGCATGCTTACTAAGATATATTG 3’
oJKM11: amplify trxB fragment with promoter from RN6390 incorporating Eco R1 site
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5’ CCGAATTCCCTCGAAACGTTACAAAGAAGC 3’
oJKM12: reverse primer for oJKM11 with Bam H1 site
5’ GCGGATCCCATACCAGCTGGACCTGCACCG 3’
oJKM13: amplify spx with flanking genes, trpsS and mecA, from RN6390
5’ GAGGCACTAGTTAATTCT 3’
oJKM14: reverse primer for oJKM13
5’ AGACTCCAAAGAGTCTCC 3’
oJKM15: amplify trpS from pJKM20 incorporating Sac I site
5’ CTTTATTTGAGCTCTTACGTCCTAAACCCATCGC 3’
oJKM16: reverse primer for oJKM13 incorporating Not I site
5’ GATTTCATCGCGGCCCGCTTCAGTCATTTT 3’
oJKM17: amplify mecA from pJKM20 incorporating Bam H1 site
5’ CAAGAGGATCCTGGCTTATTACGTC 3’
oJKM18: reverse primer for oJKM15 incorporating Hind III site
5’ AGAGACTCCAAAGCTTCTCCTTTCATAG 3’
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Appendix II
Plasmids:
Plasmid
pCR 2.1-TOPO
pET9a
PJKM10
pJKM11
pJKM12
pJKM13
pJKM14
pLL28
pJKM20
pJKM21
pJKM22
pJKM23
pJKM24
pJKM30
pJKM31
pJKM32
pJKM33

Description
Source
E. coli subcloning vector
Invitrogen
Recombinant protein overexpression vector
Novagen
Wild-type Spx coding region in pCR 2.1-TOPO
This study
Wild-type Spx coding region in pET9a
This study
Spx coding region bearing C10A mutation in pET9a
This study
Spx coding region bearing C13A mutation in pET9a
This study
Spx coding region bearing C10/13A mutation in pET9a This study
E. coli-S. aureus shuttle vector to replace gene with
Chia Lee
cat marker
spx locus with flanking genes, trpS and mecA,
This study
in pCR 2.1-TOPO
trpS in pCR 2.1-TOPO
This study
mecA in pCR 2.1-TOPO
This study
trpS in pLL28
This study
trpS/mecA in pLL28
This study
trpS/spx5’ in pCR 2.1-TOPO
This study
mecA/spx3’ in pCR 2.1-TOPO
This study
trpS/spx5’ in pLL28
This study
trpS/spx5’/mecA/spx3’ in pLL28
This study
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